Therapeutic Goods (Poisons Standard—February 2023) Instrument 2022 (Cth)
Therapeutic Goods (Poisons Standard—February 2023) Instrument 2022
I, Benjamin Noyen, as delegate of the Secretary of the Department of Health and Aged Care, make the following instrument.
Dated 3 November 2022
Benjamin Noyen
Assistant Secretary
Regulatory Engagement Branch
Health Products Regulation Group
Department of Health and Aged Care
Contents
Reader’s guide i
Introduction i
Classification iii
Principles of scheduling iv
Reading the schedules v
Availability of poisons vii
Appendicesviii
Appendix A (General exemptions) viii
Appendix B (Substances considered not to require control by scheduling) ix
Appendix C (blank) ix
Appendix D (Additional controls on possession or supply of poisons included in Schedule 4 or 8) ix
Appendix E (First aid instructions for poisons) ix
Appendix F (Warning statements and general safety directions for poisons) x
Appendix G (Dilute preparations) x
Appendix H (Schedule 3 medicines permitted to be advertised) x
Appendix I (blank) x
Appendix J (Conditions for availability and use of certain poisons included in Schedule 7) x
Appendix K (Human medicines required to be labelled with a sedation warning) x
Appendix L (Requirements for dispensing labels for medicines) x
Appendix M (blank) x
Poisons Information Centre telephone numbers for first aid instructions, warning statements and general safety directions for poisons xi
Part 1—Preliminary and interpretation 1
1............ Name............................................................................................................................. 1
2............ Commencement............................................................................................................. 1
3............ Authority....................................................................................................................... 1
4............ Repeal and transitional provisions................................................................................. 1
5............ Reader’s guide and Index.............................................................................................. 2
6............ Definitions..................................................................................................................... 2
7............ References to substances............................................................................................. 10
8............ References to concentration, strength or quantity of substances.................................. 11
9............ References to boiling or distillation temperatures........................................................ 11
10.......... References to standards............................................................................................... 11
Part 2—Controls on substances 12
Division 1—Preliminary 12
11.......... Application of Part 2................................................................................................... 12
12.......... Preparations containing poisons included in different schedules................................. 12
Division 2—Labels 13
Subdivision A—General 13
13.......... General requirements................................................................................................... 13
14.......... Immediate wrapper...................................................................................................... 13
Subdivision B—Primary packs and immediate containers 13
15.......... Primary packs and immediate containers..................................................................... 13
16.......... Signal words............................................................................................................... 14
17.......... Cautionary statement—possession without authority illegal........................................ 14
18.......... Cautionary statement—keep out of reach of children.................................................. 15
19.......... Cautionary statement—fire and explosion hazard........................................................ 15
20.......... Cautionary statement—burns skin and throat.............................................................. 15
21.......... Cautionary statements for aqueous solution of paraquat.............................................. 16
22.......... Cautionary statement—read safety directions.............................................................. 16
23.......... Cautionary statement—flammable............................................................................... 17
24.......... Cautionary statement—for animal treatment only........................................................ 17
25.......... Cautionary statement—do not swallow....................................................................... 17
26.......... Approved name and quantity, proportion or strength.................................................. 17
27.......... Statement—an anticholinesterase compound............................................................... 18
28.......... Directions for use........................................................................................................ 18
29.......... Safety directions.......................................................................................................... 19
30.......... Warning statements..................................................................................................... 19
31.......... First aid....................................................................................................................... 20
32.......... Name and address of manufacturer or distributor........................................................ 20
33.......... Warning statements and sedation warnings for certain medicines for human use........ 21
Subdivision C—Statements of quantity, proportion or strength 21
34.......... Statements of quantity, proportion or strength............................................................. 21
Subdivision D—Exemptions from labelling requirements 22
35.......... Selected containers and measure packs........................................................................ 22
36.......... Ampoules, pre‑filled syringes and injection vials........................................................ 23
37.......... Transport containers and wrappings............................................................................ 23
38.......... Dispensary, industrial, laboratory and manufacturing poisons.................................... 23
39.......... Exemptions from label requirements in certain circumstances..................................... 24
40.......... Dispensed medicines................................................................................................... 24
41.......... Gas cylinders............................................................................................................... 24
42.......... Paints........................................................................................................................... 24
43.......... Camphor and naphthalene........................................................................................... 25
Subdivision E—Prohibitions 25
44.......... Prohibitions................................................................................................................. 25
Division 3—Containers 27
45.......... General requirements................................................................................................... 27
46.......... Containers for poisons other than poisons included in Schedule 5.............................. 27
47.......... Containers for poisons included in Schedule 5............................................................ 27
48.......... Approved containers................................................................................................... 28
49.......... Child‑resistant closures............................................................................................... 28
50.......... Poisons included in Schedule 8................................................................................... 30
51.......... Exemptions.................................................................................................................. 30
52.......... Camphor and naphthalene........................................................................................... 31
53.......... Prohibitions—use of containers for poisons............................................................... 31
Division 4—Storage 32
54.......... General storage requirements...................................................................................... 32
Division 5—Disposal 33
55.......... General disposal requirements..................................................................................... 33
Division 6—Record keeping 34
56.......... General record‑keeping requirements.......................................................................... 34
Division 7—Advertising 35
57.......... General advertising requirements................................................................................ 35
Division 8—Supply, prescribing, possession or use 36
58.......... Poisons included in Schedule 2................................................................................... 36
59.......... Poisons included in Schedule 3................................................................................... 36
60.......... Poisons included in Schedule 4................................................................................... 37
61.......... Poisons included in Schedules 5 and 6........................................................................ 37
62.......... Poisons included in Schedule 7................................................................................... 37
63.......... Poisons included in Schedule 10................................................................................. 38
64.......... Poisons included in Schedule 4 or 8 and Appendix D................................................ 38
65.......... Hawking...................................................................................................................... 39
Division 9—Paints and tinters 40
66.......... General requirements................................................................................................... 40
67.......... Definition of first group paint..................................................................................... 40
68.......... Definition of second group paint................................................................................ 41
Schedule 1—Blank 42
Schedule 2—Pharmacy medicines 43
Schedule 3—Pharmacist only medicines 61
Schedule 4—Prescription only medicines and prescription animal remedies 69
Schedule 5—Caution 170
Schedule 6—Poisons 204
Schedule 7—Dangerous poisons 257
Schedule 8—Controlled drugs 270
Schedule 9—Prohibited substances 275
Schedule 10—Substances of such danger to health as to warrant prohibition of supply and use 283
Appendix A—General exemptions 289
1............ Exempt preparations and products............................................................................. 289
Appendix B—Substances considered not to require control by scheduling 292
1............ Reasons for including substances in the table in clause 3.......................................... 292
2............ Areas of use in relation to substances included in the table in clause 3...................... 292
3............ Substances exempt in certain uses............................................................................. 294
Appendix C—Blank 302
Appendix D—Additional controls on possession or supply of poisons included in Schedule 4 or 8 303
1............ Poisons available for human use only from or on the prescription or order of an authorised medical practitioner 303
2............ Poisons available for human use only from or on the prescription or order of a specialist physician or a dermatologist.................................................................................................................................. 303
3............ Poisons available only from or on the prescription or order of a medical practitioner approved or authorised under section 19 of the Act.................................................................................................. 304
4............ Poisons available only from or on the order of a specialist physician........................ 304
5............ Poisons for which possession without authority is illegal......................................... 304
6............ Poisons available for human use only from or on the prescription or order of a specialist physician 305
7............ Poisons available for human use only from or on the prescription or order of a dermatologist 306
8............ Poison available for initial treatment of a patient only if authorised by certain health practitioners 306
9............ Poisons which must be stored in a locked container to prevent unauthorised access. 306
10.......... Poison available only when prescribed or authorised in certain circumstances.......... 307
Appendix E—First aid instructions for poisons 308
1............ Standard statements for first aid instructions............................................................. 308
2............ Poisons information centre contact information in statements................................... 309
3............ First aid instructions for poisons............................................................................... 309
Appendix F—Warning statements and general safety directions for poisons 320
1............ Warning statements................................................................................................... 320
2............ Safety directions—general......................................................................................... 324
3............ Poisons information centre contact information in statements................................... 326
4............ Poisons that must be labelled with warning statements and safety directions............ 326
Appendix G—Dilute preparations 341
1............ Substances exempt at or below certain concentrations............................................... 341
Appendix H—Schedule 3 medicines permitted to be advertised 343
1............ Schedule 3 medicines permitted to be advertised....................................................... 343
Appendix I—Blank 345
Appendix J—Conditions for availability and use of certain poisons included in Schedule 7 346
1............ Conditions for supply of certain poisons included in Schedule 7.............................. 346
Appendix K—Human medicines required to be labelled with a sedation warning 349
1............ Human medicines required to be labelled with a sedation warning............................ 349
Appendix L—Requirements for dispensing labels for medicines 354
1............ General...................................................................................................................... 354
2............ Additional warning statements for certain human medicines..................................... 354
Appendix M—Additional controls or supply requirements for poisons included in Schedule 3 to allow them to be provided by a pharmacist 357
Index 358
Reader’s guide
Introduction
This instrument is made under paragraph 52D(2)(b) of the Therapeutic Goods Act 1989 (the Act), and is a compilation of decisions made under section 52D of the Act. This instrument should be read in conjunction with the Scheduling Policy Framework (the SPF) of the Australian Health Ministers’ Advisory Council. Further information on the scheduling amendments and the SPF can be viewed on the Therapeutic Goods Administration’s website ( Refer to section 6 for definitions of specific terms used in this document including “medicine” and “poison” (noting that the definition of poison includes medicine).
This instrument serves 2 key purposes.
Firstly, this instrument contains the decisions of the Secretary of the Department of Health or the Secretary’s delegates regarding the classification of poisons into Schedules, as recommendations to Australian States and Territories. The scheduling classification sets the level of control on the availability of poisons. The scheduling of poisons is implemented through relevant State and Territory legislation. Certain advertising, labelling and packaging requirements may also be a consequence of scheduling, but are the subject of other Commonwealth registration schemes.
Secondly, this instrument includes provisions for labelling, containers, storage, disposal, record‑keeping, supply and possession of poisons in general which are intended to be adopted for use in each jurisdiction of Australia. Other government agencies may also impose controls on certain products.
The requirements for labelling and containers in this instrument are intended to integrate with existing legislative instruments for labelling and containers. Advertising, labelling and packaging of therapeutic goods and agricultural and veterinary chemicals are also dealt with through the respective product registration schemes provided for in Commonwealth legislation.
Poisons which are packed and sold solely for industrial, manufacturing, laboratory or dispensary use are exempt from all labelling requirements included in this instrument as they are covered by labelling requirements under applicable jurisdictional Work Health and Safety laws, as amended from time to time. Note, however that this exemption does not extend to controls on supply of these poisons.
This instrument is presented with a view to promoting uniform:
scheduling of poisons throughout Australia; and
signal headings on labels for poisons throughout Australia; and
labelling and packaging requirements for poisons throughout Australia; and
additional controls on the availability and use of poisons in Australia.
The various Commonwealth Acts, legislative instruments and other documents, which integrate with this instrument include the following:
the Act;
the Agricultural and Veterinary Chemicals Code Act 1994;
the Agricultural and Veterinary Chemicals Code Regulations 1995;
the Therapeutic Goods Order No. 91 ‑ Standard for labels of prescription and related medicines;
the Therapeutic Goods Order No. 92 ‑ Standard for labels of non‑prescription medicines;
the Therapeutic Goods (Standard for Medicinal Cannabis) (TGO 93) Order 2017;
the Therapeutic Goods Order No. 95 ‑ Child‑resistant packaging requirements for medicines 2017 (TGO 95);
the Therapeutic Goods (Standard for Nicotine Vaping Products) (TGO 110) Order 2021;
the Therapeutic Goods (Medicines Advisory Statements) Specification 2021 – Schedule 1 Required Advisory Statements for Medicine Labels No. 6 (RASML).
Classification
Poisons are classified according to the Schedules in which they are included. The following is a general description of the Schedules. For the legal definitions, however, it is necessary to check with each relevant State or Territory authority.
| Schedule | Title | Description |
| Schedule 1 | Blank | This Schedule is intentionally blank. |
| Schedule 2 | Pharmacy medicines | Substances, the safe use of which may require advice from a pharmacist and which should be available from a pharmacy or, where a pharmacy service is not available, from a licensed person. |
| Schedule 3 | Pharmacist only medicines | Substances, the safe use of which requires professional advice but which should be available to the public from a pharmacist without a prescription. |
| Schedule 4 | Prescription only medicines and prescription animal remedies | Substances, the use or supply of which should be by or on the order of persons permitted by State or Territory legislation to prescribe and should be available from a pharmacist on prescription. |
| Schedule 5 | Caution | Substances with a low potential for causing harm, the extent of which can be reduced through the use of appropriate packaging with simple warnings and safety directions on the label. |
| Schedule 6 | Poisons | Substances with a moderate potential for causing harm, the extent of which can be reduced through the use of distinctive packaging with strong warnings and safety directions on the label. |
| Schedule 7 | Dangerous poisons | Substances with a high potential for causing harm at low exposure and which require special precautions during manufacture, handling or use. These poisons should be available only to specialised or authorised users who have the skills necessary to handle them safely. Special regulations restricting their availability, possession, storage or use may apply. |
| Schedule 8 | Controlled drugs | Substances which should be available for use but require restriction of manufacture, supply, distribution, possession and use to reduce abuse, misuse and physical or psychological dependence. |
| Schedule 9 | Prohibited substances | Substances which may be abused or misused, the manufacture, possession, supply or use of which should be prohibited by law except when required for medical or scientific research, or for analytical, teaching or training purposes with approval of Commonwealth and/or State or Territory Health Authorities. |
| Schedule 10 (previously Appendix C) | Substances of such danger to health as to warrant prohibition of supply and use | Substances which are prohibited for the purpose or purposes listed for each poison. |
Principles of scheduling
Poisons are not scheduled on the basis of a universal scale of toxicity. Although toxicity is one of the factors considered, and is itself a complex of factors, the decision to include a substance in a particular Schedule also takes into account many other criteria such as the purpose of use, potential for abuse, safety in use and the need for the substance.
This instrument lists poisons in 10 Schedules according to the degree of control recommended to be exercised over their availability to the public.
Poisons for therapeutic use (medicines) are mostly included in Schedules 2, 3, 4 and 8 with progression through these Schedules signifying increasingly restrictive regulatory controls.
For some medicines and agricultural, domestic and industrial poisons, Schedules 5, 6 and 7 represent increasingly stricter container and labelling requirements with special regulatory controls over the availability of the poisons listed in Schedule 7. Products for domestic use must not include poisons listed in Schedule 7.
Schedule 9 contains substances that should be available only for teaching, training, medical or scientific research including clinical trials conducted with the approval of Commonwealth and/or State and Territory health authorities. Although appearing as a Schedule in this instrument, the method by which it is implemented in the States and Territories may vary.
Schedule 10 (previously Appendix C) contains a list of substances or preparations, the supply or use of which should be prohibited because of their known dangerous properties.
Substances in products which have been considered for scheduling, but have been exempted from this instrument, may be listed in either Appendix A (general exemptions) or Appendix B (substances considered not to require control by scheduling).
Reading the schedules
Schedule entries have been designed to be as simple as possible while retaining readability, legal integrity and as much freedom from ambiguity and contradiction as possible. As a result, they are expressed in a number of ways, though this number has been kept to a minimum. It is necessary to keep this variety of expression in mind when searching or interpreting Schedule entries.
Firstly, poisons are scheduled individually using their approved names wherever practicable although exceptions are necessary in some cases. Some of those are mentioned below. Older group entries are revised and replaced by individual entries as time permits, although in some of these cases a group term has also been retained to deal with any members of the group or class that may have escaped attention but should be scheduled.
Secondly, Schedule entries have been expressed in either positive or negative terms and care must be taken to distinguish between the 2 different forms of expression. Thus, selenium is in Schedule 6 only when one of the clauses in this Schedule entry applies, while fluorides are in Schedule 6 unless one of the exempting clauses applies.
Where exceptions are included in an entry, these have been emphasised by printing the word “except” in bold type.
Where the Schedule entries for a poison make a specific exclusion or exemption, the requirements of this instrument do not apply to that poison within the constraints of that exclusion or exemption although controls under other legislation, such as pesticide registration, may apply.
Where a Schedule entry for a poison requires a specific statement to be included on a label as a condition for a product to qualify for an exemption (“reverse scheduling”), then in cases where it is impracticable for a supplier to use the exact wording of such a statement, its wording may be varied provided that the full intent and meaning of the statement is not changed.
Where a poison has been included in more than one Schedule, the principal entry, where practicable, has been included in the most restrictive Schedule with references to the other Schedule(s) involved.
It is important to remember that a Schedule entry includes preparations containing the poison in any concentration and all salts and derivatives of the poison unless it specifically states otherwise (see section 7).
It is important to note that a substance is not classed as a derivative on the basis of a single, prescriptive set of criteria. Classification of a substance as a derivative of a scheduled poison relies on a balanced consideration of factors to decide if a substance has a similar nature (e.g. structurally, pharmacologically, and toxicologically) to a scheduled poison or is readily converted (either physically or chemically) to a scheduled poison. However, a substance is only considered a derivative of a scheduled poison if it is not individually listed elsewhere in the Schedules, or captured by a more restrictive group or class entry. Additionally, some entries specifically exclude derivatives. Once a substance is determined to be a derivative of a scheduled poison, the same scheduling requirements as the scheduled poison, including limits on access, supply and availability, will apply.
Finally, when using this instrument to determine the scheduling status of a poison, it may be necessary to search each relevant Schedule as well as Appendices A, B and the Index. In this process, if the poison is not found under its “approved name” it may be shown under a group term such as:
| Group | Example |
| the parent acid of salts | “oxalic acid” to find sodium oxalate |
| the radical of a salt | “chromates” to find potassium chromate |
| the element | “arsenic” to find arsenic trioxide |
| a chemical group with similar toxicological or pharmacological activity | “hydrocarbons, liquid” to find kerosene |
| a pharmacological group | “anabolic steroidal agents” to find “androsterone” |
Availability of poisons
The purpose of classification is to group substances into Schedules that require similar regulatory controls over their availability.
These Schedules have been developed over a long period and contain poisons that may be obsolete for various reasons. Also, as part of the move to harmonise the Australian and New Zealand classifications, many substances have been added to the Schedules for that purpose, irrespective of their availability in either country.
Inclusion of a poison in a Schedule indicates the degree of control required if it is marketed. It does not:
indicate that the poison is available; or
indicate that it is has been approved or is efficacious for any use that may be specified in a Schedule; or
negate any obligation for registration of therapeutic goods, or agricultural or veterinary chemical product containing that poison.
Appendices
Some substances in certain circumstances are also subject to exemptions or additional restrictions as described in the Appendices of this instrument. The table below summarises the purpose of each of the Appendices and the controls imposed on substances included in them.
| Appendix | Title | Purpose/controls imposed |
| Appendix A | General exemptions | List of preparations and products exempted from this instrument. |
| Appendix B | Substances considered not to require control by scheduling | List of poisons exempted from scheduling. |
| Appendix C | Appendix is intentionally left blank | See Schedule 10. |
| Appendix D | Additional controls on possession or supply of poisons included in Schedule 4 or 8 | List of poisons included in Schedule 4 or 8 where additional specified controls apply on possession or supply. |
| Appendix E | First aid instructions for poisons | First aid instructions for poisons (other than agricultural and veterinary chemicals and chemicals packed and sold solely for industrial, dispensary, manufacturing or laboratory use). |
| Appendix F | Warning statements and general safety directions for poisons | Warning statements and general safety directions for poisons (other than human medicines, agricultural and veterinary chemicals and chemicals packed and sold solely for industrial, dispensary, manufacturing or laboratory use). |
| Appendix G | Dilute preparations | Concentration cut‑offs for specified poisons, below which the requirements of this instrument do not apply |
| Appendix H | Schedule 3 medicines permitted to be advertised | List of medicines included in Schedule 3 that are permitted to be advertised to the public. |
| Appendix I | Appendix is intentionally left blank | |
| Appendix J | Conditions for availability and use of Schedule 7 poisons | List of poisons included in Schedule 7 where additional specified conditions apply to their availability and use. |
| Appendix K | Human medicines required to be labelled with a sedation warning | List of poisons in medicines for human use required to be labelled with a warning regarding their sedation potential. |
| Appendix L | Requirements for dispensing labels for medicines | Requirements applying to labels attached to medicines at the time of dispensing. |
| Appendix M | Additional controls or supply requirements for poisons included in Schedule 3 to allow them to be provided by a pharmacist Appendix is intentionally left blank and is reserved for future use. |
Appendix A (General exemptions)
Appendix A lists preparations and products that are exempted from this instrument.
Appendix B (Substances considered not to require control by scheduling)
Substances for which the available information suggests that inclusion in the Poisons Schedules is not necessary, or not the most appropriate means of controlling the risk to public health, have been considered at various times.
Inclusion in Appendix B indicates that a decision has been taken not to include substances anywhere in the Schedules, either for a specific purpose, or generally. It is an inclusive, but not an exhaustive, list (that is, there may be substances not included in the Schedules, and not included in Appendix B, which may be hazardous or non‑hazardous, but have not been considered in relation to the need for scheduling).
Substances may be included in Appendix B because they have intrinsically low toxicity, or where other factors suggest that the potential public health risk would be minimal. Factors which are considered when determining an Appendix B entry include:
the toxicology profile was adequately characterised and not consistent with inclusion in any of the Schedules;
the use, purpose or product presentation minimised any hazard to the public such as to not require scheduling; or
the public access was limited such that scheduling was inappropriate or unnecessary.
The list of substances included in Appendix B was developed from scheduling files and historical records. For transparency, where the reason for entry and/or purpose or use for the substance was apparent in the consideration, this has been included in the columns “Reason for Entry” and “Area of Use”.
Inclusion in Appendix B will not prevent reconsideration of the scheduling of a substance where adverse information becomes available about the Appendix B entry for that substance.
Applications are considered for scheduling. Applications for inclusion in Appendix B will not be accepted.
Appendix C (blank)
Appendix C is intentionally blank.
Appendix D (Additional controls on possession or supply of poisons included in Schedule 4 or 8)
Appendix D lists poisons included in Schedule 4 or 8 where additional specified controls apply on possession or supply.
Appendix E (First aid instructions for poisons)
Under poisons legislation, scheduled substances and their preparations are required to be labelled with appropriate directions for first aid attention in case of poisoning. It is the responsibility of the manufacturer, packer and supplier of a drug or poison to ensure that the first aid instructions included on the label of a poison are appropriate for a specific product. Standard statements have been prepared as a guide for health authorities and manufacturers in drafting suitable first aid directions for this purpose. Standard statements specified in Appendix E may be varied provided that the intent is not changed.
The directions listed for any particular substance may require modification to take into account combination of that substance with other substances, both toxic and non‑toxic, in a formulation, as well as the physical form and presentation of the product. Any such modification should be concise and readily understood.
The First Aid Instructions include action to be taken in case of eye contamination from substances recognised as causing direct poisoning via the eye, causing severe eye damage or requiring prolonged flushing to free the absorbed substance from the eye tissue. However, it is recognised that many other substances or preparations will require a statement of varying nature depending on the detailed formulation. While the necessity to flush the eyes in case of accident will be so self‑evident as not to justify label space in many instances, a statement such as “If in eyes rinse well with water” may be appropriate.
Appendix F (Warning statements and general safety directions for poisons)
It is the responsibility of the manufacturer, packer and supplier of a drug or poison to ensure that the purchaser or user of a product is given sufficient information to be able to use it correctly and safely.
Under poisons legislation, scheduled substances, which may be harmful to the user, must be labelled with appropriate warning statements and/or safety directions. The selection of warning statements and safety directions will depend on the formulation of the product, and the use for which it is sold or supplied. Warning statements and safety directions have been prepared as a guide for this purpose.
The wording of warning statements and safety directions specified in Appendix F may be varied provided that the intent is not changed. Additional statements also may be added to ensure that the user of a product is sufficiently advised of its harmful nature and how to avoid any deleterious effects.
Appendix G (Dilute preparations)
Appendix G lists concentration cut‑offs for specified substances, below which the requirements of this instrument do not apply.
Appendix H (Schedule 3 medicines permitted to be advertised)
Appendix H lists medicines included in Schedule 3 that are permitted to be advertised to the public.
Appendix I (blank)
Appendix I is intentionally blank.
Appendix J (Conditions for availability and use of certain poisons included in Schedule 7)
All poisons included in Appendix J are not to be available except to authorised or licensed persons.
The use of a poison may be restricted for a particular purpose. Controls recommended for the Schedule 7 poisons included in Appendix J may be implemented through poisons controls or other State or Territory legislation.
Appendix K (Human medicines required to be labelled with a sedation warning)
Medicines for human use that contain a poison included in Appendix K are required to be labelled with a warning regarding their sedation potential.
Appendix L (Requirements for dispensing labels for medicines)
Appendix L sets out the requirements for labels attached to medicines at the time of dispensing.
Appendix M (blank)
Appendix M is intentionally blank and is reserved for future use.
Poisons Information Centre telephone numbers for first aid instructions, warning statements and general safety directions for poisons
Companies should use the Poisons Information Centre telephone number(s) (Australia 13 11 26; New Zealand 0800 764 766) appropriate to the country(ies) of sale for the product.
Companies wishing to use a poisons information centre telephone number other than the national telephone numbers for Australia and New Zealand must meet the following criteria:
1. the poisons information service whose number is used must be attended by adequately trained staff for 24 hour emergency poisons information; and
2. calls must be logged and submitted for incorporation into the official collection of poisoning data.
Part 1—Preliminary and interpretation
1 Name
(1) This instrument is the Therapeutic Goods (Poisons Standard—February 2023) Instrument 2022.
(2) This instrument may also be cited as the Standard for the Uniform Scheduling of Medicines and Poisons No. 38.
Note: This instrument is the current Poisons Standard for the purposes of the Act until a document is prepared in substitution for it (see sections 52A and 52D of the Act).
2 Commencement
(1) Each provision of this instrument specified in column 1 of the table commences, or is taken to have commenced, in accordance with column 2 of the table. Any other statement in column 2 has effect according to its terms.
| Commencement information | ||
| Column 1 | Column 2 | Column 3 |
| Provisions | Commencement | Date/Details |
| 1. The whole of this instrument | 1 February 2023. | 1 February 2023 |
Note: This table relates only to the provisions of this instrument as originally made. It will not be amended to deal with any later amendments of this instrument.
(2) Any information in column 3 of the table is not part of this instrument. Information may be inserted in this column, or information in it may be edited, in any published version of this instrument.
3 Authority
This instrument is made under paragraph 52D(2)(b) of the Therapeutic Goods Act 1989.
4 Repeal and transitional provisions
Repeal
(1) The Poisons Standard October 2022 is repealed.
Transitional—things done under the repealed instrument
(2) If:
(a) a thing was done for a particular purpose under the Poisons Standard October 2022 as in force immediately before that instrument was repealed; and
(b) the thing could be done for that purpose under this instrument;
the thing has effect for the purposes of this instrument as if it had been done for that purpose under this instrument.
(3) Without limiting subsection (2), a reference in that subsection to a thing being done includes a reference to an approval, authorisation, certificate, exemption, requirement or other instrument being given, made, granted or issued.
5 Reader’s guide and Index
(1) The Reader’s guide is not part of this instrument.
(2) The Index is not part of this instrument.
6 Definitions
Note 1: The following expressions used in this instrument are defined in the Act:
(a) current Poisons Standard;
(b) poison;
(c) Register;
(d) Secretary;
(e) supply;
(f) therapeutic goods.
Note 2: The definition of poison in the Act is as follows:
poison means an ingredient, compound, material or preparation which, or the use of which, may cause death, illness or injury and includes any ingredient, compound, material or preparation referred to in a schedule to the current Poisons Standard.
In this instrument:
Act means the Therapeutic Goods Act 1989.
agricultural chemical means:
(a) a substance that is represented, imported, manufactured, supplied or used as a means of directly or indirectly:
(i) destroying, stupefying, repelling, inhibiting the feeding of, or preventing infestation by or attacks of, any pest in relation to a plant, a place or a thing; or
(ii) destroying a plant; or
(iii) modifying the physiology of a plant or pest so as to alter its natural development, productivity, quality or reproductive capacity; or
(iv) modifying an effect of another agricultural chemical; or
(v) attracting a pest for the purpose of destroying it; or
(b) an active ingredient included in a product declared by regulation under the Agricultural and Veterinary Chemicals Code Act 1994 to be an agricultural chemical product;
but does not include a veterinary chemical.
agricultural chemical product has the same meaning as in the Agricultural and Veterinary Chemicals Code set out in the Schedule to the Agricultural and Veterinary Chemicals Code Act 1994.
animal means any animal (other than a human being), whether vertebrate or not, and whether a food producing species or not, and includes mammals, birds, bees, reptiles, amphibians, fish, crustaceans and molluscs.
animal feed premix means a concentrated preparation, containing one or more poisons, for mixing with food ingredients to produce a bulk feed for a group of animals (including fish or birds), but does not include a preparation for mixing with an individual animal’s food.
appropriate authority: each of the following is an appropriate authority:
(a) each person who is the head of the body (however described) in a State or Territory that is responsible for the administration of matters relating to health in that State or Territory;
(b) the Deputy Secretary of the Department with responsibility for the part of the Department known as the Therapeutic Goods Administration, or their delegate;
(c) the Chief Executive Officer of the Australian Pesticides and Veterinary Medicines Authority, or their delegate.
approved name means:
(a) for a poison that is for human therapeutic use—the name for the poison in the Australian Approved Names List within the meaning of the Therapeutic Goods Regulations 1990; or
(b) for a poison that is for animal or agricultural use—the name approved for use by the Australian Pesticides and Veterinary Medicines Authority under the Agricultural and Veterinary Chemicals Code set out in the Schedule to the Agricultural and Veterinary Chemicals Code Act 1994; or
(c) for any other poison—the name for the poison mentioned in the first‑occurring of the following paragraphs that applies to the poison:
(i) the name used for the poison in this instrument;
(ii) the name recommended by Standards Australia as the common name for the poison;
(iii) the English name given to the poison by the International Organization for Standardization;
(iv) the name given to the poison by the British Standards Institution;
(v) the English name given to the poison by the European Committee for Standardization (CEN);
(vi) the international non‑proprietary name recommended for the poison by the World Health Organization;
(vii) the International Nomenclature Cosmetic Ingredient name for the poison listed in the International Cosmetic Ingredient Dictionary & Handbook published by the Personal Care Products Council of America;
(viii) the accepted scientific name or the name descriptive of the true nature and origin of the poison.
Australian Dangerous Goods Code means the Australian Code for the Transport of Dangerous Goods by Road & Rail, published by the National Transport Commission, as existing from time to time.
Note: The Australian Dangerous Goods Code could in 2022 be viewed on the Commission’s website ( prescriber means any of the following:
(a) a dental practitioner;
(b) a medical practitioner;
(c) a veterinarian;
(d) a person for whom an authorisation, given for the purposes of this paragraph by an appropriate authority, is in effect.
blood means whole blood extracted from human donors.
blood components means therapeutic components that have been manufactured from blood (including red cells, white cells, stem cells, platelets and plasma), except for products derived through fractionation of plasma.
child‑resistant closure means:
(a) a closure that complies with the requirements for a child‑resistant closure in Australian Standard AS 1928‑2007, Child‑resistant packaging – Requirements and testing procedures for reclosable packages (ISO 8317:2015, MOD); or
(b) a closure that complies with the requirements for child‑resistant closures specified in Therapeutic Goods Order No. 95 ‑ Child‑resistant packaging requirements for medicines 2017 (TGO 95); or
(c) a closure that is taken to comply with the requirements mentioned in paragraph (b) under Therapeutic Goods (Standard for Nicotine Vaping Products) (TGO 110) Order 2021; or
(d) in the case of a can fitted with a press‑on lid, a lid of the design known as “double tight” or “triple tight”.
Note: See also the definition of non‑access packaging.
child‑resistant packaging means packaging that:
(a) complies with the requirements of Australian Standard AS 1928‑2007, Child resistant packaging – Requirements and testing procedures for reclosable packages (ISO 8317:2015, MOD); or
(b) is reclosable and complies with the requirements of at least one of the following:
(i) the International Organization for Standardization Standard ISO 8317:2015, Child‑resistant packaging—Requirements and testing procedures for reclosable packages;
(ii) the British Standards Institution Standard BS EN ISO 8317:2004, Child‑resistant packaging—Requirements and testing procedures for reclosable packages;
(iii) the Canadian Standards Association Standard CSA Z76.1‑06, Reclosable Child‑Resistant Packages;
(iv) the United States Code of Federal Regulations, Title 16, Section 1700.15, Poison prevention packaging standards and Section 1700.20, Testing procedure for special packaging, as in force from time to time; or
(c) a closure that complies with the requirements for child‑resistant packaging specified in Therapeutic Goods Order No. 95 ‑ Child‑resistant packaging requirements for medicines 2017 (TGO 95); or
(d) a closure that is taken to comply with the requirements mentioned in paragraph (c) under Therapeutic Goods (Standard for Nicotine Vaping Products) (TGO 110) Order 2021; or
(e) is in the form of blister or strip packaging:
(i) in which a unit of use is individually protected until the time of release; and
(ii) that complies with section 3 (Requirements for non‑reclosable packages) of Australian Standard AS 1928‑2001, Child‑resistant packages.
Note: See also the definition of non‑access packaging.
compounded in relation to a substance means combined with one or more other therapeutically active substances in such a way that it cannot be separated from them by simple dissolution or other simple physical means.
cosmetic means a substance or preparation intended for placement in contact with any external part of the human body, including:
(a) the mucous membranes of the oral cavity; and
(b) the teeth;
with a view to:
(c) altering the odours of the body; or
(d) changing its appearance; or
(e) cleansing it; or
(f) maintaining it in good condition; or
(g) perfuming it; or
(h) protecting it.
debitterised neem seed oil means highly purified oil from the neem seed containing only fatty acids and glycerides of fatty acids.
dental practitioner means a person who is registered, in a State or internal Territory, as a dental practitioner (other than a dental therapist, dental hygienist, dental prosthetist or oral health therapist).
dermal use means application to the skin primarily for localised effect.
designated solvent means the following:
(a) acetone;
(b) dimethylformamide;
(c) N‑(N‑dodecyl)‑2‑pyrrolidone;
(d) hydrocarbons, liquid;
(e) methanol when included in Schedule 5;
(f) methyl ethyl ketone;
(g) methyl isoamyl ketone;
(h) methyl isobutyl ketone;
(i) N‑methyl‑2‑pyrrolidone;
(j) N‑(N‑octyl)‑2‑pyrrolidone;
(k) phenyl methyl ketone;
(l) styrene;
(m) tetrachloroethylene;
(n) 1,1,1‑trichloroethane.
dispensing label, for a substance for therapeutic use, means the label attached to the immediate container of the substance at the time of dispensing.
Note: See section 40 and Appendix L.
distributor means a person who imports or supplies a poison.
divided preparation means a preparation manufactured and packed as discrete pre‑measured dosage units prior to supply, and includes tablets, capsules, cachets, single dose powders or single dose sachets of powders or granules.
dosage unit means an individual dose of a poison for therapeutic use and includes a tablet, capsule, cachet, single dose powder or single dose sachet of powders or granules.
drug means a poison intended for human or animal therapeutic use.
essential oils means:
(a) products obtained from natural raw materials by distillation with water or steam or from the epicarp of citrus fruits by a mechanical process, or by dry distillation; or
(b) oils of equivalent composition to products mentioned in paragraph (a) that are derived through synthetic means; or
(c) prepared mixtures of oils of equivalent composition to products mentioned in paragraph (a) that comprise a mixture of synthetic and natural components.
external in relation to the use of a poison means application in the ears, eyes or nose or to a body surface other than in the mouth, rectum, vagina, urethra or other body orifice.
first group paint: see section 67.
free formaldehyde includes all hydrated and non‑hydrated formaldehyde present in aqueous solution, including methylene glycol and formaldehyde released from formaldehyde donors.
graphic material means the material which is to be deposited on another material by a graphic instrument during writing, drawing or marking and includes cores of pencils, school pastels or crayons, blackboard chalks, finger or showcard colours, poster paints and watercolour blocks.
hand sanitiser preparation means an antimicrobial skin care product that:
(a) consists of, contains or generates one or more antimicrobial active substances; and
(b) is represented in any way to be, or is likely to be taken to be (whether because of the way in which it is presented or for any other reason):
(i) for use on hands when soap and water are not available; and
(ii) applied to the hands without rinsing off; and
(iii) intended to destroy, deter, render harmless, prevent the action of, or otherwise exert a controlling effect on any microbes on the skin.
hawking means to supply (including peddle or distribute or cause to be distributed) in a public place.
height in relation to letters used for words, expressions or statements on labels means the height of capital letters or lower case letters having an ascender or a descender.
hemp seed oil means the oil obtained by cold expression from the ripened fruits (seeds) of Cannabis sativa.
immediate container includes all forms of containers in which a poison is directly packed but does not include any such container intended for consumption or any immediate wrapper.
immediate wrapper means metal foil, plastic foil, waxed paper, or any other such material not intended for consumption, when used as the first wrapper for a dosage unit or dressing.
internal use means administration:
(a) orally, except for topical effect in the mouth; or
(b) for absorption and the production of a systemic effect:
(i) by way of a body orifice other than the mouth; or
(ii) parenterally, other than by application to unbroken skin.
label:
(a) means a written statement on a container of a poison; and
(b) in relation to therapeutic goods, includes a display of printed information about the product:
(i) on, or attached to, the goods; or
(ii) on, or attached to, a container or primary pack in which the goods are supplied; or
(iii) supplied with such a container or pack.
main label, for a container of poison, means:
(a) the part of the label that is most likely to be displayed, presented, shown, or examined under ordinary or customary conditions of display; and
(b) if there are 2 or more labels:
(i) the label or the part of the label where the product name is more or most conspicuously shown; or
(ii) if the product name is equally more or most conspicuously displayed on more than one of those labels—each of the labels on which the product name is equally more or most conspicuously displayed.
manufacturer of a poison means a person who manufactures, produces, or packs a poison.
marker dyes or pigments means any product that is added to a liquid used in agricultural or veterinary chemicals to identify or distinguish treated from untreated objects, land or organisms by temporarily imparting colour on the relevant object, land or organism through, for example, spot‑ or boom‑spraying.
measure pack means a sealed container which contains a measured quantity of poison for use on one occasion as a pesticide or domestic product and one or more of which is enclosed in a primary pack.
medical practitioner means a person who is registered, in a State or internal Territory, as a medical practitioner.
medicine means any poison for therapeutic use.
midwife means a person who is registered, in a State or internal Territory, as a midwife.
non‑access packaging, for a product that is not intended for human therapeutic use, means packaging that complies with the requirements of AS 4710‑2001, Packages for chemicals not intended for access or contact with their contents by humans.
Note: See also the definitions of child‑resistant closure and child‑resistant packaging.
non‑volatile content in relation to a paint or tinter means that portion of a paint or tinter determined to be the non‑volatile content by Method 301.1 of Australian Standard AS 1580‑301.1‑2005, Paints and related materials – Methods of test – Non‑volatile content by mass.
nurse means a person who is registered, in a State or internal Territory, as a nurse.
oromucosal use means administration to the oral mucosa, specifically the oral cavity and/or the pharynx.
paint includes any substance used or intended to be used for application as a colouring or protective coating to any surface but does not include graphic material or paints for therapeutic use.
pesticide means any substance or mixture of substances used or intended to be used:
(a) for preventing, destroying, repelling, attracting, inhibiting or controlling any insects, rodents, birds, nematodes, bacteria, fungi, weeds or other forms of plant or animal life or viruses, which are pests; or
(b) as a plant regulator, promoter, defoliant or desiccant for food storage, household, industrial, commercial, agricultural and non‑agricultural application, but does not include veterinary drugs, stock medicines, stock feeds, stock feed additives, drugs for human use, food additives or fertilisers.
pharmacist means a person who is registered, in a State or internal Territory, as a pharmacist.
primary pack, in relation to a poison, means the pack in which the poison and its immediate container or immediate wrapper or measure pack are presented for supply.
product sample means a packed poison supplied directly to a consumer:
(a) free of charge or for a nominal charge; and
(b) as a mechanism to promote the supply of the product; and
(c) in the form of:
(i) a small pack produced specifically for the purposes of promotion; or
(ii) a normal commercial pack that in other circumstances could be purchased by the consumer.
public place means any place where members of the public are lawfully entitled, invited or permitted to be present in their capacity as members of the public.
Note: Examples of a public place include a street, road, footway, court, alley or thoroughfare that the public may use in any residential premises or to get from door to door, place to place or house to house.
required advisory statements for medicine labels means the Therapeutic Goods (Medicines Advisory Statements) Specification 2021.
restricted flow insert means a restriction:
(a) that is fitted or moulded in the neck of a container; and
(b) that cannot readily be removed from the container by manual force; and
(c) that limits the delivery of the contents of the container to drops each of which is not more than 200 microlitres.
second group paint: see section 68.
selected container means:
(a) an injection vial having a nominal capacity of 10 ml or less; or
(b) a single use syringe; or
(c) any other container for substances for therapeutic use having a nominal capacity of 10 ml or less.
solid includes powder.
substance has the same meaning as in Part 6‑3 of the Act.
Note 1: In general terms, that definition covers an ingredient, compound, material or preparation which, or the use of which, may cause death, illness or injury to persons or animals.
Note 2: See also section 7.
therapeutic use means use in or in connection with:
(a) preventing, diagnosing, curing or alleviating a disease, ailment, defect or injury in human beings or animals; or
(b) influencing, inhibiting or modifying a physiological process in human beings or animals; or
(c) testing the susceptibility of human beings or animals to a disease or ailment; or
(d) influencing, controlling or preventing conception in human beings or animals; or
(e) testing for pregnancy in human beings or animals; or
(f) the replacement or modification of parts of the anatomy in human beings or animals.
tinter means any pigment or admixture of pigment with other substances, in powder, semi‑solid or liquid form, sold or supplied for the purpose of adding to paint in order to change the colour of the paint.
topical use means application of a poison for the purpose of producing a localised effect on the surface of the organ or within the tissue to which it is applied.
toy means an object or number of objects manufactured, designed, labelled or marketed as a plaything for a child or children up to the age of 14 years.
transdermal use means application to the skin primarily for systemic effect.
veterinarian means a person who is registered under the law of a State or Territory as a veterinarian, a veterinary practitioner or a veterinary surgeon.
veterinary chemical means:
(a) a substance that is represented as being suitable for, or is manufactured, supplied or used for, administration or application to an animal by any means, or consumption by an animal, as a way of directly or indirectly:
(i) preventing, diagnosing, curing or alleviating a disease or condition in the animal or an infestation of the animal by a pest; or
(ii) curing or alleviating an injury suffered by the animal; or
(iii) modifying the physiology of the animal:
(A) so as to alter its natural development, productivity, quality or reproductive capacity; or
(B) so as to make it more manageable; or
(iv) modifying the effect of another veterinary chemical; or
(b) any vitamin, mineral substance, or additive, if, and only if, the vitamin, substance or additive is used for a purpose mentioned in paragraph (a); or
(c) any active ingredient included in a product declared by regulation under the Agricultural and Veterinary Chemicals Code Act 1994 to be a veterinary chemical product;
but does not include an agricultural chemical.
veterinary chemical product has the same meaning as in the Agricultural and Veterinary Chemicals Code set out in the Schedule to the Agricultural and Veterinary Chemicals Code Act 1994.
7 References to substances
In this instrument, unless the contrary intention appears, a reference to a substance includes the following:
(a) that substance prepared from natural sources or artificially;
(b) if the substance is a plant (other than a plant included in Schedule 8 or 9)—that plant or any part of that plant when packed or prepared for therapeutic use;
(c) every salt, active principle or derivative of the substance, including esters and ethers, and every salt of such an active principle or derivative;
(d) every alkaloid of the substance and every salt of such an alkaloid;
(e) every stereoisomer of the substance and every salt of such a stereoisomer;
(f) every recombinant form of the substance;
(g) a preparation or admixture containing any proportion of the substance.
Note: Part 2 (controls on substances) does not apply in relation to certain substances (see section 11).
8 References to concentration, strength or quantity of substances
In this instrument, for a reference to a concentration, strength or quantity of a substance:
(a) if the substance is present as a salt, active principle or derivative (including an ester or ether), the concentration, strength or quantity is calculated as the equivalent amount of the substance; and
(b) the expression “1%” means:
(i) in the case of a liquid preparation, 1 g of the substance per 100 mL of the preparation; or
(ii) in the case of a solid, semi‑solid or pressurised spray aerosol preparation, 1 g of the substance per 100 g of the preparation; and
(iii) any expression of greater or lesser percentages shall have a corresponding meaning; and
(c) in the case of codeine, such concentration, strength or quantity is calculated as anhydrous codeine.
9 References to boiling or distillation temperatures
In this instrument, a reference to a boiling or distillation temperature means that temperature at an atmospheric pressure of 101.325 kPa (760 mL of mercury).
10 References to standards
A reference in this instrument to an Australian standard, an international standard or a standard of a foreign country is a reference to that standard as it exists from time to time.
Part 2—Controls on substances
Division 1—Preliminary
Application of Part 2
This Part applies to a substance or preparation included in a schedule to this instrument, other than the following:
(a) a preparation or product included in the table in clause 1 of Appendix A;
(b) a substance included in the table in clause 3 of Appendix B when used in an area, sub‑area or sub‑sub‑area of use specified in the table in relation to that substance;
(c) a substance included in the table in clause 1 of Appendix G at a concentration not exceeding the concentration specified in that table in relation to that substance;
(d) any other substance included in Schedules 1 to 6, at a concentration not exceeding 10 mg per litre or 10 mg per kilogram, unless that substance is also included in Schedule 7 or 8;
(e) any substance present as an impurity in a pesticide, at a concentration at or below the maximum content for that substance, specified for the pesticide in the APVMA standards for active constituents for use in agricultural chemical products, published by the Australian Pesticides and Veterinary Medicines Authority, as existing from time to time.
Note: For paragraph (e), the APVMA standards could in 2022 be viewed on the Australian Pesticides and Veterinary Medicines Authority’s website ( Preparations containing poisons included in different schedules
(1) If a preparation contains 2 or more poisons, the provisions relating to each of the schedules in which those poisons are included apply to the preparation.
(2) However, if it is not possible to comply both with a provision relating to one of those schedules and with a provision relating to another of those schedules, the provision relating to the more restrictive schedule applies, unless a contrary intention is indicated in the schedules or relevant State or Territory legislation.
(3) The Schedules listed in order of greatest to least restrictiveness are 9, 10, 8, 4, 7, 3, 2, 6, 5.
Note: Schedule 1 is not currently in use.
Division 2—Labels
Subdivision A—General
13 General requirements
(1) A poison must not be supplied unless it is labelled in accordance with this Division.
(2) Any word, expression or statement required by this instrument to be written on a label or container must be written:
(a) on the outside face of the label or container; and
(b) in English; and
(c) in durable characters; and
(d) in a colour or colours to provide a distinct contrast to the background colour; and
(e) in letters at least 1.5 mm in height.
(3) Paragraph (2)(e) does not apply to a word, expression or statement on a container which has a capacity of 20 ml or less, or on the label of such a container if:
(a) an appropriate authority approves the use of smaller letters; and
(b) the letters are at least 1 mm in height.
(4) The label must be printed on, or securely attached to:
(a) the outside of the immediate container; and
(b) if the immediate container is enclosed in a primary pack—the outside of that primary pack.
14 Immediate wrapper
If a poison is enclosed in an immediate wrapper:
(a) the poison must be contained in a primary pack labelled in accordance with section 15; and
(b) the immediate wrapper must be conspicuously labelled with:
(i) the name of the manufacturer or distributor or the brand name or trade name used exclusively by the manufacturer or distributor for that poison; and
(ii) the approved name of the poison; and
(iii) a statement of the quantity, proportion or strength of the poison in accordance with section 34.
Subdivision B—Primary packs and immediate containers
15 Primary packs and immediate containers
This Subdivision sets out how the primary pack and immediate container of a poison must be labelled.
16 Signal words
(1) The signal word or words for the poison, as shown in the following table, must be written:
(a) on the first line or lines of the main label; and
(b) in bold‑face sans serif capital letters of uniform thickness; and
(c) subject to subsection (3), in letters at least half the height of the largest letter or numeral on the label; and
(d) with nothing else other than the following written on the same line or lines:
(i) if the poison is included in Schedule 5—a class label as specified in the Australian Dangerous Goods Code or a statement of the principal hazard of the poison;
(ii) if the poison is not included in Schedule 5—a class label as specified in the Australian Dangerous Goods Code.
Signal word or words for poisons Item For a poison included in the following schedule … that is to be used for the following purpose … the signal word or words are … 1 Schedule 2 for any purpose PHARMACY MEDICINE 2 Schedule 3 for any purpose PHARMACIST ONLY MEDICINE 3 Schedule 4 for human use PRESCRIPTION ONLY MEDICINE 4 Schedule 4 for animal use PRESCRIPTION ANIMAL REMEDY 5 Schedule 5 for any purpose CAUTION 6 Schedule 6 for any purpose POISON 7 Schedule 7 for any purpose DANGEROUS POISON 8 Schedule 8 for any purpose CONTROLLED DRUG (2) For the purposes of paragraph (1)(c), the largest letter or numeral does not include:
(a) a single letter or numeral which is larger than other lettering on the label; or
(b) an affix forming part of the trade name for the poison; or
(c) in the case of a poison for therapeutic use—numerals used to distinguish the strength of a preparation from the strengths of other preparations of the same poison.
(3) For the purposes of paragraph (1)(c), the letters need not be larger than:
(a) 6 mm on labels for packages having a nominal capacity of 2 L or less; or
(b) 15 mm on labels for packages having a nominal capacity of more than 2 L.
17 Cautionary statement—possession without authority illegal
If the poison is included in Schedule 8, the cautionary statement:
POSSESSION WITHOUT AUTHORITY ILLEGAL
must be written:
(a) on a separate line or lines immediately below the signal words required by section 16; and
(b) in bold‑face sans serif capital letters of uniform thickness; and
(c) in letters at least four‑tenths the height of the letters used for the signal words; and
(d) with no other statement written on the same line or lines.
18 Cautionary statement—keep out of reach of children
The cautionary statement:
KEEP OUT OF REACH OF CHILDREN
must be written:
(a) on a separate line or lines:
(i) immediately below the signal word or words required by section 16; or
(ii) if the cautionary statement “POSSESSION WITHOUT AUTHORITY ILLEGAL” is required by section 17—immediately below that statement; and
(b) in bold‑face sans serif capital letters of uniform thickness; and
(c) in letters at least four‑tenths the height of the letters used for the signal word or words; and
(d) with nothing, other than a class label as specified in the Australian Dangerous Goods Code, written on the same line or lines.
19 Cautionary statement—fire and explosion hazard
(1) If the poison is a dry chlorinating compound containing more than 10% of available chlorine, the cautionary statement:
FIRE AND EXPLOSION HAZARD
must be written:
(a) on a separate line or lines immediately below the cautionary statement “KEEP OUT OF REACH OF CHILDREN” as required by section 18; and
(b) in bold‑face sans serif capital letters of uniform thickness; and
(c) in letters at least four‑tenths the height of the letters used for the signal word or words; and
(d) with nothing, other than a class label as specified in the Australian Dangerous Goods Code, written on the same line or lines.
(2) This section does not apply to a preparation certified by a relevant State or Territory authority as not being a Dangerous Good of Class 5, Division 5.1: Oxidising substances, as specified in the Australian Dangerous Goods Code.
20 Cautionary statement—burns skin and throat
If the poison is an alkaline salt in a dishwashing machine product, the cautionary statement:
BURNS SKIN AND THROAT
must be written:
(a) on a separate line or lines immediately below the cautionary statement “KEEP OUT OF REACH OF CHILDREN” as required by section 18; and
(b) in bold‑face sans serif capital letters of uniform thickness; and
(c) in letters at least four‑tenths the height of the letters used for the signal word; and
(d) with nothing, other than a class label as specified in the Australian Dangerous Goods Code, written on the same line or lines of the main label.
21 Cautionary statements for aqueous solution of paraquat
If the poison is an aqueous solution of paraquat, the cautionary statements:
CAN KILL IF SWALLOWED
DO NOT PUT IN DRINK BOTTLES
KEEP LOCKED UP
must be written:
(a) on separate lines immediately below the cautionary statement “KEEP OUT OF REACH OF CHILDREN” as required by section 18; and
(b) in bold‑face sans serif capital letters of uniform thickness; and
(c) in letters at least four‑tenths the height of the letters used for the signal words; and
(d) with nothing, other than a class label as specified in the Australian Dangerous Goods Code, written on the same lines of the main label.
22 Cautionary statement—read safety directions
(1) If safety directions are required on the label by section 29, the following cautionary statement:
READ SAFETY DIRECTIONS BEFORE OPENING OR USING
or the following cautionary statement:
READ SAFETY DIRECTIONS
must be written:
(a) on a separate line or lines:
(i) immediately below the cautionary statement “KEEP OUT OF REACH OF CHILDREN” as required by section 18; or
(ii) if one or more other cautionary statements is required to be on the line immediately below “KEEP OUT OF REACH OF CHILDREN”, immediately below that statement or those statements; and
(b) in bold‑face sans serif capital letters of uniform thickness; and
(c) in letters at least four‑tenths the height of the letters used for the signal word or words; and
(d) with nothing, other than a class label as specified in the Australian Dangerous Goods Code, written on the same line or lines.
(2) This section does not apply to a medicine for human use that is labelled in accordance with the required advisory statements for medicine labels.
23 Cautionary statement—flammable
If the poison meets the criteria for a “flammable liquid” in the Australian Dangerous Goods Code, the cautionary statement:
FLAMMABLE
must be written on the main label in bold‑face sans serif capital letters of uniform thickness, unless already present in accordance with the requirements of the Australian Dangerous Goods Code.
24 Cautionary statement—for animal treatment only
If the poison is only for the treatment of animals, the cautionary statement:
FOR ANIMAL TREATMENT ONLY
must be written on the main label in bold‑face sans serif capital letters of uniform thickness.
25 Cautionary statement—do not swallow
If the poison is included in Schedule 5 and is intended for any purpose other than internal or pesticidal use, the cautionary statement:
DO NOT SWALLOW
must be written in sans serif capital letters on the main label or as part of the directions for use.
26 Approved name and quantity, proportion or strength
(1) The approved name of the poison and a statement of the quantity, proportion or strength of the poison in accordance with section 34 must be:
(a) if the poison is for human therapeutic use—written on the main label in accordance with the standards for the goods specified in orders made under subsection 10(1) of the Act; or
(b) if the poison is not for human therapeutic use—written in bold‑face sans serif capital letters on the main label, unless:
(i) a list of approved names is required; and
(ii) it is impractical to include the list on the main label; and
(iii) it is included on another part of the label in accordance with an authorisation given by an appropriate authority.
(2) If the poison is included in Schedule 5 and is referred to in column 1 of an item of the following table, the appropriate name in column 2 of that item may be used as the approved name.
Appropriate names for poisons Item Column 1
PoisonColumn 2
Appropriate name1 Alkaline salts Alkaline salts 2 Amines for use as curing agents for epoxy resins (unless separately specified in the Schedules) Aliphatic amines or aromatic amines 3 Epoxy resins, liquid Liquid epoxy resins 4 Hydrocarbons, liquid Liquid hydrocarbons 5 Quaternary ammonium compounds Quaternary ammonium compound(s) (3) If a poison contains a mixture of designated solvents in excess of 25% of the total volume of the poison but the proportion of one or more individual designated solvents in the mixture is equal to or less than 25%, the approved names of those solvents may be expressed as follows:
(a) where the designated solvent is a liquid hydrocarbon—as “liquid hydrocarbons”;
(b) where the designated solvent is a ketone—as “ketones”;
(c) in any other case—as “solvents” or “other solvents”.
27 Statement—an anticholinesterase compound
(1) If the poison is an organophosphorus compound or carbamate for pesticidal use or for the treatment of animals, the following expression:
AN ANTICHOLINESTERASE COMPOUND
must be written immediately below the approved name or the list of declared contents on the label.
(2) This section does not apply to:
(a) dazomet, mancozeb, metiram, propineb, thiram, tri‑allate, zineb or ziram; or
(b) an organophosphorus compound or carbamate contained in impregnated plastic resin strips, medallions or granules; or
(c) an organophosphorus compound or carbamate contained in a pressurised spray pack for household use.
28 Directions for use
If the poison is prepared, packed or sold for a specific purpose, it must be labelled with clear and adequate directions for use, unless:
(a) it is a medicine for human use that is labelled in accordance with:
(i) Therapeutic Goods Order No. 91 ‑ Standard for labels of prescription and related medicines; or
(ii) Therapeutic Goods Order No. 92 ‑ Standard for labels of non‑prescription medicines; or
(b) it is in an agricultural or veterinary chemical product labelled in compliance with the Agricultural and Veterinary Chemicals Code Act 1994; or
(c) it is included in Schedule 4 or 8; or
(d) all of the following apply:
(i) it is impractical to include such directions on the label;
(ii) the primary pack and the immediate container are labelled with the statement “DIRECTIONS FOR USE: See package insert”;
(iii) an appropriate authority has authorised the directions for use to be written on a package insert instead of the label;
(iv) the insert is enclosed in the primary pack.
29 Safety directions
(1) If the poison is included in the table in clause 4 of Appendix F, it must be labelled with each safety direction required for the poison by that clause, grouped together as a distinct section of the label and prefaced by the words:
SAFETY DIRECTIONS
written in bold‑face capital letters.
(2) This section does not apply to the following:
(a) a poison that:
(i) is a medicine for human use; and
(ii) is labelled in accordance with the required advisory statements for medicine labels;
(b) a poison that:
(i) is an agricultural chemical or a veterinary chemical; and
(ii) is a registered chemical product within the meaning of the Agricultural and Veterinary Chemicals Code set out in the Schedule to the Agricultural and Veterinary Chemicals Code Act 1994.
30 Warning statements
(1) If the poison is included in the table in clause 4 of Appendix F, it must be labelled with each warning statement required for the poison by that clause, grouped together:
(a) if safety directions are included on the label—immediately after the words “SAFETY DIRECTIONS”; or
(b) if there are no safety directions—immediately preceding the directions for use.
(2) This section does not apply to the following:
(a) a poison that:
(i) is a medicine for human use; and
(ii) is labelled in accordance with the required advisory statements for medicine labels;
(b) a poison that:
(i) is an agricultural chemical or a veterinary chemical; and
(ii) is a registered chemical product within the meaning of the Agricultural and Veterinary Chemicals Code set out in the Schedule to the Agricultural and Veterinary Chemicals Code Act 1994.
31 First aid
(1) If the poison is included in the table in clause 3 of Appendix E, it must be labelled with each statement required for the poison by clause 3 of Appendix E:
(a) grouped together and prefaced by the following words:
FIRST AID
written in bold‑face capital letters; or
(b) if a primary pack contains 2 or more immediate containers of poisons each requiring different first aid instructions:
(i) written on each immediate container as specified in paragraph (a); and
(ii) replaced on the primary pack with the statement:
FIRST AID: See inner packs.
(2) This section does not apply to the following:
(a) a poison that:
(i) is for human internal use; and
(ii) is included in Schedule 3, 4 or 8;
(b) a poison that:
(i) is a medicine for human use; and
(ii) is labelled in accordance with the required advisory statements for medicine labels;
(c) a poison that:
(i) is an agricultural chemical or a veterinary chemical; and
(ii) is a registered chemical product within the meaning of the Agricultural and Veterinary Chemicals Code set out in the Schedule to the Agricultural and Veterinary Chemicals Code Act 1994.
32 Name and address of manufacturer or distributor
(1) The poison must be labelled with the name and address of its manufacturer or distributor. The address:
(a) must be a physical address in Australia; and
(b) must not be a post office, cable, telegraphic or code address.
(2) However, if the manufacturer or distributor is a company incorporated under the law of a State or Territory, or a firm registered under a law of a State or Territory dealing with business names, the name and address may be:
(a) the registered name of the corporation or firm, or its branch or division; and
(b) the city or town in which a registered office of the company or firm is situated.
33 Warning statements and sedation warnings for certain medicines for human use
Warning statements for certain medicines
(1) A dispensed medicine for human use containing a poison included in column 1 of the table in clause 2 of Appendix L must be clearly labelled with each warning statement required for the poison by that clause.
Sedation warning for certain medicines
(2) A dispensed medicine for human use containing a poison included in Appendix K must be clearly labelled with a warning statement set out in item 39, 40 or 90 of the table in clause 1 of Appendix F.
Subdivision C—Statements of quantity, proportion or strength
34 Statements of quantity, proportion or strength
(1) The statement of the quantity, proportion or strength of a poison must be expressed in the most appropriate of the following forms:
(a) if the poison is for human therapeutic use—the manner required by the standards for the goods specified in orders made under subsection 10(1) of the Act;
(b) if the poison is for a purpose or purposes other than human therapeutic use—as follows:
Schedule 4
PHOLCODINE
Schedule 8
Schedule 4
Schedule 2
Appendix K, clause 1
PHORATE
Schedule 7
PHOSALONE
Schedule 6
PHOSFOLAN
Schedule 7
PHOSMET
Schedule 6
PHOSPHIDES, METALLIC
cross reference: ALUMINIUM PHOSPHIDE, MAGNESIUM PHOSPHIDE, ZINC PHOSPHIDE
Schedule 7
Appendix J, clause 1
PHOSPHINE
Schedule 7
Appendix J, clause 1
PHOSPHODIESTERASE TYPE 5 INHIBITORS
Schedule 4
PHOSPHONIC ACID
cross reference: PHOSPHOROUS ACID
Schedule 5
Appendix E, clause 3
Appendix F, clause 4
PHOSPHORIC ACID
Schedule 6
Schedule 5
Appendix E, clause 3
Appendix F, clause 4
PHOSPHORUS
Appendix G, clause 1
PHOSPHORUS, YELLOW
Schedule 7
Appendix E, clause 3
Appendix F, clause 4
PHOTOGRAPHIC PAPER or FILM
Appendix A, clause 1
PHOXIM
Schedule 6
o‑PHTHALADEHYDE
Appendix F, clause 4
o‑PHTHALALDEHYDE
Appendix E, clause 3
PHTHALALDEHYDE
Schedule 6
Schedule 5
PHTHALYLSULFATHIAZOLE
Schedule 4
PHYSOSTIGMINE
Schedule 4
PHYTASE
Appendix B, clause 3
PIBRENTASVIR
Schedule 4
PICARIDIN
Schedule 5
PICLORAM
Appendix B, clause 3
PICOLINAFEN
Appendix B, clause 3
PICRAMIC ACID (including its salts)
cross reference: 2‑AMINO‑4,6‑DINITROPHENOL
Schedule 6
Appendix E, clause 3
Appendix F, clause 4
PICRIC ACID
Appendix E, clause 3
Appendix F, clause 4
PICROTOXIN
Schedule 4
PIGMENTS
Appendix A, clause 1
PILOCARPINE
Schedule 4
PIMECROLIMUS
Schedule 4
PIMELIC ACID
Appendix B, clause 3
PIMINODINE
Schedule 9
PIMOBENDAN
Schedule 4
PIMOZIDE
Schedule 4
Appendix K, clause 1
PINACIDIL
Schedule 4
PINDOLOL
Schedule 4
PINDONE
Schedule 6
PINE OILS
Schedule 6
Schedule 5
PINOXADEN
Schedule 6
Schedule 5
PIOGLITAZONE
Schedule 4
PIPECURONIUM
Schedule 4
PIPEMIDIC ACID
Schedule 4
PIPENZOLATE
Schedule 4
PIPER METHYSTICUM
cross reference: KAVA, KAVALACTONES
Schedule 4
PIPERACILLIN
Schedule 4
PIPERAZNE
Schedule 5
Schedule 2
PIPERIDINE
Schedule 4
PIPERIDOLATE
Schedule 4
PIPERONYL BUTOXIDE
Appendix B, clause 3
PIPEROPHOS
Schedule 6
PIPOBROMAN
Schedule 4
PIPOTHIAZINE
Schedule 4
PIPRADROL
Schedule 4
PIRACETAM
cross reference: RACETAMS
Schedule 4
PIRBUTEROL
Schedule 4
PIRENOXINE
cross reference: CATALIN
Schedule 4
PIRENZEPINE
Schedule 4
PIRETANIDE
Schedule 4
PIRFENIDONE
Schedule 4
PIRIMICARB
Schedule 6
Schedule 5
PIRIMIPHOS‑ETHYL
Schedule 6
PIRIMIPHOS‑METHYL
Schedule 6
PIRITRAMIDE
Schedule 8
PIROXICAM
Schedule 4
PIRPROFEN
Schedule 4
PITAVASTATIN
Schedule 4
PITUITARY HORMONES
Schedule 4
PIVAMPICILLIN
Schedule 4
PIZOTIFEN
Schedule 4
Appendix K, clause 1
PLASMID DNA (rE. coli DH5α pINGhT)
cross reference: VACCINES – PLASMID DNA
PLERIXAFOR
Schedule 4
PLICAMYCIN
Schedule 4
PLITIDEPSIN
Schedule 4
Appendix L, clause 2
PNEUMOCOCCAL VACCINE
Schedule 4
PODOPHYLLOTOXIN
cross reference: PODOPHYLLIN
Schedule 4
Schedule 3
Schedule 2
Appendix F, clause 4
Appendix H, clause 1
PODOPHYLLUM EMODI
cross reference: PODOPHYLLIN
Schedule 4
Schedule 3
Schedule 2
Appendix F, clause 4
Appendix H, clause 1
PODOPHYLLUM PELTATUM
cross reference: PODOPHYLLIN
Schedule 4
Schedule 3
Schedule 2
Appendix F, clause 4
Appendix H, clause 1
PODOPHYLLUM RESIN
cross reference: PODOPHYLLIN
Appendix G, clause 1
POLIHEXANIDE
cross reference: 1‑(DIAMINOMETHYLIDENE)‑2‑HEXYLGUANIDINE, POLY (IMINOCARBONIMIDOYLIMINOCARBONIMIDOYL IMINO‑1,6‑HEXANEDIYL), POLYHEXAMETHYLENE BIGUANIDE (PHMB)
Schedule 6
Appendix E, clause 3
Appendix F, clause 4
POLIOMYELITIS VACCINE
Schedule 4
POLIXETONIUM SALTS
Schedule 6
Schedule 5
POLOXALENE
Appendix B, clause 3
POLY (GNRF) OVALBUMIN
Appendix B, clause 3
POLY DIALLYL DIMETHYL AMMONIUM CHLORIDE
cross reference: POLYDADMAC
Appendix B, clause 3
POLY(OXY‑1,2‑ETHANEDIYL), α ‑[2‑[(2‑HYDROXYETHYL)AMINO]‑2‑OXOETHYL]‑ α ‑HYDROXY‑,MONO‑C13‑15‑ALKYL ETHERS
Schedule 5
Appendix E, clause 3
POLYACRYLAMIDE
Schedule 4
POLYCAPROLACTONE
Schedule 4
POLYESTRADIOL
Schedule 4
POLYETHANOXY (15) TALLOW AMINE
Schedule 5
Appendix E, clause 3
POLYHEDROSIS VIRUS of Helico zea occlusion bodies
Appendix B, clause 3
POLYLACTIC ACID
Schedule 4
POLYMYXIN
Schedule 4
POLYOXIN D ZINC SALT
Schedule 5
POLYSORBATE 20
Appendix B, clause 3
POLYSULFATED GLYCOSAMINOGLYCANS
Schedule 4
POLYTHIAZIDE
Schedule 4
POMALIDOMIDE
Schedule 4
Appendix D, clause 4
Appendix F, clause 4
Appendix L, clause 2
PONATINIB
Schedule 4
PONESIMOD
Schedule 4
Appendix L, clause 2
PORACTANT
Schedule 4
PORCELAIN
Appendix A, clause 1
PORCINE SOMATOTROPHIN
Appendix B, clause 3
POSACONAZOLE
Schedule 4
POTASSIUM AZELOYL DIGLYCINATE
Schedule 6
POTASSIUM BICARBONATE
Appendix B, clause 3
POTASSIUM BROMATE
Schedule 6
Appendix E, clause 3
POTASSIUM BROMIDE
Schedule 4
POTASSIUM CHLORATE
Schedule 5
Schedule 2
Appendix E, clause 3
POTASSIUM CHLORIDE
Schedule 4
POTASSIUM CYANATE
Schedule 6
Appendix E, clause 3
POTASSIUM HYDROXIDE
Schedule 10
Schedule 6
Schedule 5
Appendix E, clause 3
Appendix F, clause 4
POTASSIUM METABISULPHITE
Schedule 5
Appendix F, clause 4
POTASSIUM NITRITE
Schedule 7
Schedule 6
Schedule 5
Appendix E, clause 3
Appendix F, clause 4
POTASSIUM PERCHLORATE
Schedule 4
POTASSIUM PEROXOMONOSULFATE TRIPLE SALT
Schedule 6
Schedule 5
POTASSIUM PERSULFATE
Schedule 6
Appendix E, clause 3
Appendix F, clause 4
POTASSIUM SORBATE
Appendix B, clause 3
POTASSIUM SULFIDE
Schedule 5
Appendix E, clause 3
Appendix F, clause 4
PRACTOLOL
Schedule 4
PRADOFLOXACIN
Schedule 4
PRALATREXATE
Schedule 4
PRALIDOXIME
Schedule 4
PRALLETHRIN
Schedule 6
Schedule 5
PRALMORELIN (GROWTH HORMONE RELEASING PEPTIDE‑2) (GHRP‑2)
Schedule 4
Appendix D, clause 5
PRAMIPEXOLE
Schedule 4
PRAMIRACETAM
cross reference: RACETAMS
Schedule 4
PRAMOCAINE
Schedule 4
PRAMPINE
Schedule 4
PRASTERONE
cross reference: DEHYDROEPIANDROSTERONE, DEHYDROISOANDROSTERONE
Schedule 4
Appendix D, clause 5 (Anabolic and/or androgenic steroidal agents)
PRASUGREL
Schedule 4
PRAVASTATIN
Schedule 4
PRAZEPAM
Schedule 4
Appendix D, clause 5 (Benzodiazepine derivatives)
Appendix K, clause 1
PRAZIQUANTEL
Schedule 4
PRAZOSIN
Schedule 4
PREDNISOLONE
Schedule 4
PREDNISONE
Schedule 4
PREGABALIN
Schedule 4
Appendix K, clause 1
PREGNENOLONE
Schedule 4
PRENALTEROL
Schedule 4
PRENYLAMINE
Schedule 4
PRILOCAINE
Schedule 4
Schedule 2
PRIMAQUINE
Schedule 4
PRIMIDONE
Schedule 4
PRINTING INKS or INK ADDITIVES
Appendix A, clause 1
PROBENECID
Schedule 4
PROBUCOL
Schedule 4
PROCAINAMIDE
Schedule 4
PROCAINE
Schedule 4
PROCAINE BENZYLPENICILLIN
Schedule 4
PROCAINE PENICILLIN
cross reference: PROCAINE BENZYLPENICILLIN
PROCARBAZINE
Schedule 4
PROCHLORAZ
Schedule 6
PROCHLORPERAZINE
Schedule 4
Schedule 3
Appendix K, clause 1
PROCYCLIDINE
Schedule 4
Schedule 2
PROCYMIDONE
Schedule 7
PROFENOFOS
Schedule 6
PROFOXYDIM
Schedule 5
PROGESTERONE
Schedule 5
Schedule 4
Appendix G, clause 1
PROGESTOGENS
Schedule 4
PROGLUMIDE
Schedule 4
PROGUANIL
Schedule 4
PROHEPTAZINE
Schedule 9
PROHEXADIONE CALCIUM
Schedule 5
PROLINTANE
Schedule 4
PROMACYL
Schedule 6
PROMAZINE
Schedule 4
Appendix K, clause 1
PROMETHAZINE
Schedule 4
Schedule 3
Schedule 2
Appendix K, clause 1
PROMETRYN
Schedule 5
PROMOXOLANE
Schedule 4
PROPACHLOR
Schedule 6
PROPAFENONE
Schedule 4
PROPAMIDINE
Schedule 4
Schedule 2
PROPAMOCARB
Schedule 5
PROPANIDID
Schedule 4
PROPANIL
Schedule 5
PROPANTHELINE
Schedule 4
PROPAQUIZAFOP
Schedule 5
PROPARGITE
Schedule 6
PROPENTOFYLLINE
Schedule 4
PROPERIDINE
Schedule 9
PROPETAMPHOS
Schedule 6
PROPETANDROL
Schedule 4
Appendix D, clause 5 (Anabolic and/or androgenic steroidal agents)
PROPICONAZOLE
Schedule 6
Schedule 5
PROPINEB
Schedule 6
PROPIONIBACTERIUM ACNES
Schedule 4
PROPIONIC ACID
Schedule 6
Schedule 5
Appendix E, clause 3
Appendix F, clause 4
PROPIRAM
Schedule 8
PROPOFOL
Schedule 4
PROPOXUR
Schedule 6
Schedule 5
PROPRANOLOL
Schedule 4
Appendix G, clause 1
PROPYL ACETATES
Appendix B, clause 3
n‑PROPYL ALCOHOL
Schedule 6
Schedule 5
Appendix E, clause 3
Appendix F, clause 4
n‑PROPYL NITRITE
Schedule 10
PROPYLENE GLYCOL
Appendix B, clause 3
2‑PROPYLENE GLYCOL 1‑MONOMETHYL
Appendix B, clause 3
PROPYLENE OXIDE
Schedule 7
Appendix J, clause 1
PROPYLHEXEDRINE
Schedule 4
PROPYLTHIOURACIL
Schedule 4
PROPYPHENAZONE
Schedule 4
PROPYZAMIDE
Schedule 5
PROQUAZONE
Schedule 4
PROQUINAZID
Schedule 6
PROSCILLARIDIN
Schedule 4
PROSTAGLANDINS
Schedule 4
PROSTIANOL
Schedule 4
PROSULFOCARB
Schedule 6
PROSULFURON
Schedule 6
PROTAMINE
Schedule 4
PROTHIOCONAZOLE
Appendix B, clause 3
PROTHIOCONAZOLE‑DESCHLORO
Schedule 5
PROTHIOCONAZOLE‑TRIAZOLIDINETHIONE
Schedule 5
PROTHIOFOS
Schedule 6
PROTHIONAMIDE
Schedule 4
PROTHIPENDYL
Schedule 4
PROTIRELIN
Schedule 4
PROTOVERATRINES
Schedule 4
PROTRIPTYLINE
Appendix K, clause 1
PROTRIPTYLINE
Schedule 4
PROXYMETACAINE
Schedule 4
PRUCALOPRIDE
Schedule 4
PSEUDOEPHEDRINE
Schedule 4
Schedule 3
PSEUDOMONAS FLUORESCENS
Appendix B, clause 3
PSILOCYBINE
Schedule 9
PTERIDIUM spp.
Schedule 10
d‑PULEGONE
Schedule 6
Appendix E, clause 3
PULMONARIA spp.
Schedule 10
PYDIFLUMETOFEN
Appendix B, clause 3
PYMETROZINE
Schedule 5
PYRACLOFOS
Schedule 6
PYRACLOSTROBIN
Schedule 5
PYRAFLUFEN‑ETHYL
Schedule 5
PYRANTEL
Schedule 2
PYRASULFOTOLE
Schedule 5
PYRAZINAMIDE
Schedule 4
PYRAZOLAM
Schedule 9
PYRAZOPHOS
Schedule 6
PYRETHRINS
cross reference: CHRYSANTHEMIC ACID ESTERS, CINEROLONE, JASMOLONE, PYRETHRIC ACIDS, PYRETHROLONE
Schedule 5
Schedule 2
PYRIDABEN
Schedule 6
Schedule 5
PYRIDALYL
Schedule 6
PYRIDATE
Schedule 6
PYRIDINOLCARBAMATE
Schedule 4
PYRIDOSTIGMINE
Schedule 4
PYRIDOXAL
Schedule 4
PYRIDOXAMINE
Schedule 4
PYRIDOXINE
Schedule 4
PYRIFENOX
Schedule 5
PYRIMETHAMINE
Schedule 4
PYRIMETHANIL
Appendix B, clause 3
PYRINURON
Schedule 7
Appendix J, clause 1
PYRIOFENONE
Schedule 6
Schedule 5
PYRIPROLE
Schedule 6
PYRIPROXYFEN
Appendix B, clause 3
PYRITHIOBAC SODIUM
Schedule 5
PYRITHIONE COPPER
Schedule 6
PYRITHIONE ZINC
Schedule 6
Schedule 5
Schedule 2
Appendix E, clause 3
PYROVALERONE
Schedule 4
PYROXASULFONE
Schedule 6
PYROXSULAM
Schedule 6
PYRVINIUM
cross reference: VIPRYNIUMA
Schedule 4
Q
QUASSIA
Appendix B, clause 3
QUATERNARY AMMONIUM COMPOUNDS
cross reference: BENZALKONIUM CHLORIDE, DIALKYL and DIALKOYL QUATERNARY AMMONIUM COMPOUNDS
Schedule 6
Schedule 5
Appendix E, clause 3
QUAZEPAM
Schedule 4
Appendix D, clause 5 (Benzodiazepine derivatives)
QUETIAPINE
Schedule 4
Appendix K, clause 1
QUINAGOLIDE
Schedule 4
QUINALBARBITONE
cross reference: SECOBARBITAL
QUINAPRIL
Schedule 4
QUINBOLONE
Schedule 4
Appendix D, clause 5 (Anabolic and/or androgenic steroidal agents)
QUINCLORAC
Schedule 5
QUINETHAZONE
Schedule 4
QUINIDINE
Schedule 4
QUININE
cross reference: QUININE (CAS No. 130‑95‑0), QUININE SULFATE (1:1) (CAS No. 549‑56‑4), QUININE SULFATE (2:1) (CAS No. 804‑63‑7), QUININE SULFATE (2:1) DIHYDRATE (CAS No. 6119‑70‑6), QUININE SULFATE (1:1) HEPTAHYDRATE (CAS No. 6183‑68‑2), QUININE DIHYDROCHLORIDE (CAS No. 60‑93‑5), QUININE MONOHYDROCHLORIDE (CAS No. 130‑89‑2), QUININE HYDROCHLORIDE DIHYDRATE (CAS No. 6119‑47‑7), QUININE HYDROCHLORIDE (UNSPECIFIED) (CAS No. 7549‑43‑1)
Schedule 7
Schedule 6
Schedule 5
Schedule 4
Appendix F, clause 4
QUINISOCAINE
cross reference: DIMETHISOQUINE
Schedule 4
QUINOLINE
cross reference: 2,3‑BENZAPYRIDINE
Schedule 6
Appendix E, clause 3
Appendix F, clause 4
QUINOXYFEN
Appendix B, clause 3
QUINTOZENE
cross reference: PENTACHLORONITROBENZENE
Schedule 5
QUINUPRISTIN
Schedule 4
QUIZALOFOP ETHYL
cross reference: QUIZALOFOP ETHYL (D + ISOMER)
Schedule 6
QUIZALOFOP‑p‑ETHYL
Schedule 6
Schedule 5
QUIZALOFOP‑p‑TEFURYL
Schedule 6
R
RABEPRAZOLE
Schedule 4
Schedule 3
Schedule 2
Appendix H, clause 1
RABIES VACCINE
Schedule 4
RACEMETHORPHAN
Schedule 9
RACEMORAMIDE
Schedule 8
RACEMORPHAN
Schedule 9
RACETAMS
Schedule 4
RACTOPAMINE
Schedule 5
Schedule 4
RADIOGRAPHIC CONTRAST MEDIA
cross reference: RADIOPAQUES
Appendix A, clause 1
RADIOISOTOPES
Appendix A, clause 1
RALOXIFENE
Schedule 4
RALTEGRAVIR
Schedule 4
RALTITREXED
Schedule 4
RAMIPRIL
Schedule 4
RAMUCIRUMAB
Schedule 4
RANIBIZUMAB
Schedule 4
RANITIDINE
Schedule 4
Schedule 2
Appendix F, clause 4
RANOLAZINE
Schedule 4
RAPACURONIUM
Schedule 4
RASAGILINE
Schedule 4
RASBURICASE
Schedule 4
RAUWOLFIA SERPENTINA
Schedule 4
RAUWOLFIA VOMITORIA
Schedule 4
RAZOXANE
Schedule 4
REBOXETINE
Schedule 4
RECOMBINANT VARICELLA ZOSTER VIRUS GLYCOPROTEIN E ANTIGEN
Schedule 4
RED YEAST RICE
Schedule 4
REGDANVIMAB
Schedule 4
REGORAFENIB
Schedule 4
REMIFENTANIL
Schedule 8
REMDESIVIR
Schedule 4
REMOXIPRIDE
Schedule 4
REPAGLINIDE
Schedule 4
RESCALURE
cross reference: (3S,6R)‑(3S,6S)‑6‑isopropenyl‑3‑methyldec‑9‑en‑1‑yl acetate
Schedule 6
RESERPINE
Schedule 4
RESLIZUMAB
Schedule 4
RESMETHRIN
Schedule 6
Schedule 5
RESORCINOL
cross reference: 1,3‑BENZENEDIOL
Schedule 6
Appendix E, clause 3
Appendix F, clause 4
RETAPAMULIN
Schedule 4
RETEPLASE
Schedule 4
RETIGABINE
Schedule 4
Appendix K, clause 1
RHIZOBIUM RHIZOGENES
Appendix B, clause 3
RIBAVIRIN
Schedule 4
RIBOCICLIB
Schedule 4
RIDAFOROLIMUS
Schedule 4
RIFABUTIN
Schedule 4
RIFAMPICIN
Schedule 4
RIFAMYCIN
Schedule 4
RIFAPENTINE
Schedule 4
RIFAXIMIN
Schedule 4
RILPIVIRINE
Schedule 4
RILUZOLE
Schedule 4
RIMEXOLONE
Schedule 4
RIMITEROL
Schedule 4
RIMONABANT
Schedule 4
RIMSULFURON
Schedule 5
RIOCIGUAT
Schedule 4
Appendix D, clause 4
Appendix L, clause 2
RIPRETINIB
Schedule 4
RISANKIZUMAB
Schedule 4
RISDIPLAM
Schedule 4
RISEDRONIC ACID
Schedule 4
RISPERIDONE
Schedule 4
Appendix K, clause 1
RITODRINE
Schedule 4
RITONAVIR
Schedule 4
RITUXIMAB
Schedule 4
RIVAROXABAN
Schedule 4
RIVASTIGMINE
Schedule 4
RIZATRIPTAN
Schedule 4
Schedule 3
Appendix H, clause 1
ROBENACOXIB
Schedule 4
ROBENIDINE
Schedule 5
ROFECOXIB
Schedule 4
ROFLUMILAST
Schedule 4
ROLICYCLIDINE
cross reference: PCPY, PHP
Schedule 9
ROLITETRACYCLINE
Schedule 4
ROLZIRACETAM
cross reference: RACETAMS
Schedule 4
ROMIDEPSIN
Schedule 4
ROMIFIDINE
Schedule 4
ROMIPLOSTIM
Schedule 4
ROMOSOZUMAB
Schedule 4
RONIDAZOLE
Schedule 4
ROPINIROLE
Schedule 4
ROPIVACAINE
Schedule 4
ROSEMARY OIL
Appendix B, clause 3
ROSIGLITAZONE
Schedule 4
ROSIN
cross reference: COLOPHONY
Schedule 5
ROSOXACIN
Schedule 4
ROSUVASTATIN
Schedule 4
ROTENONE
cross reference: CUBE
Schedule 6
ROTIGOTINE
Schedule 4
Appendix K, clause 1
ROXIBOLONE
Schedule 4
Appendix D, clause 5 (Anabolic and/or androgenic steroidal agents)
ROXITHROMYCIN
Schedule 4
RUBELLA VACCINE
Schedule 4
RUBOXISTAURIN
Schedule 4
RUFINAMIDE
Schedule 4
Appendix K, clause 1
Appendix L, clause 2
RUPATADINE
Schedule 4
Appendix K, clause 1
RUXOLITINIB
Schedule 4
S
SACITUZUMAB GOVITECAN
Schedule 4
SACUBITRIL
Schedule 4
SAFINAMIDE
Schedule 4
SAFLUFENACIL
Schedule 7
Schedule 5
SAFROLE
cross reference: SASSAFRAS OIL
Schedule 10
Schedule 6
Appendix E, clause 3
Appendix F, clause 4
SAGE OIL
cross reference: DALMATIAN, THUJONE
Schedule 6
Appendix E, clause 3
SAGE OIL (Spanish)
cross reference: CAMPHOR
Appendix B, clause 3
SALBUTAMOL
Schedule 4
Schedule 3
Appendix F, clause 4
SALCATONIN
cross reference: CALCITONIN SALMON
SALICYLAMIDE
cross reference: ASPIRIN, CAFFEINE, PARACETAMOL
Schedule 4
Schedule 2
Appendix F, clause 4
SALICYLANILIDE
Schedule 5
SALICYLIC ACID
cross reference: CHOLINE SALICYLATE
Schedule 3
Appendix H, clause 1
SALINOMYCIN
Schedule 6
Schedule 4
SALMETEROL
Schedule 4
SALVIA DIVINORUM
Schedule 9
SANDALWOOD OIL
Appendix B, clause 3
SANGUINARIA CANADENSIS (bloodroot)
Schedule 10
SANGUINARINE
cross reference: SANGUINARIA CANADENSIS (bloodroot)
SANTONIN
Schedule 3
SAPROPTERIN
Schedule 4
SAQUINAVIR
Schedule 4
SARILUMAB
Schedule 4
SAROLANER
Schedule 6
Schedule 5
SARS‑COV‑2 (COVID‑19) VACCINE
Schedule 4
SASSAFRAS OIL
cross reference: SAFROLE
Schedule 6
Appendix E, clause 3
Appendix F, clause 4
SAXAGLIPTIN
Schedule 4
SCHOENOCAULON OFFICINALE
cross reference: SABADILLA
Schedule 4
SCHRADAN
Schedule 7
SCOPOLIA CARNIOLICA
Schedule 4
SEAWEED
Appendix B, clause 3
SEBELIPASE ALFA
Schedule 4
SECBUTOBARBITAL
Schedule 8
Appendix K, clause 1
SECBUTOBARBITONE
cross reference: SECBUTOBARBITAL
SECOBARBITAL
Schedule 8
Appendix K, clause 1
SECUKINUMAB
Schedule 4
SEDAXANE
Schedule 5
SEEDS
Appendix A, clause 1
SELAMECTIN
Schedule 5
SELECTIVE ANDROGEN RECEPTOR MODULATORS
cross reference: SARM
Schedule 4
Appendix D, clause 5
SELEGILINE
Schedule 4
SELENIUM
cross reference: BARIUM SELENATE, SELENIUM COMPOUNDS, SELENIUM ARSENIDE, SELENIUM SULFIDE
Schedule 7
Schedule 6
Schedule 4
Schedule 2
Appendix E, clause 3
Appendix F, clause 4
Appendix G, clause 1
SELETRACETAM
Cross reference RACETAMS
Schedule 4
Appendix K, clause 1
SELEXIPAG
Schedule 4
SELINEXOR
Schedule 4
Appendix L, clause 2
SELUMETINIB
Schedule 4
Appendix L, clause 2
SEMAGLUTIDE
Schedule 4
SEMDURAMICIN
Schedule 7
Schedule 6
SENECIO spp.
Schedule 10
SERELAXIN
Schedule 4
SERMORELIN
Schedule 4
SERTINDOLE
Schedule 4
SERTRALINE
Schedule 4
SETHOXYDIM
Schedule 5
SEVELAMER
Schedule 4
SEVOFLURANE
Schedule 4
SEX HORMONES
Schedule 4
SH‑OLIGOPEPTIDE‑1, RH‑OLIGOPEPTIDE‑1
cross reference: EPIDERMAL GROWTH FACTOR
SIBUTRAMINE
Schedule 4
SIDURON
Schedule 5
SILANDRONE
Schedule 4
Appendix D, clause 5 (Anabolic steroidal agent)
SILDENAFIL
Schedule 4
SILICOFLUORIDES
cross reference: BARIUM SILICOFLUORIDE, FLUORIDES, FLUOROSILICATES, HEXAFLUOROSILICATES MAGNESIUM FLUOSILICATE,
Schedule 6
Schedule 5
SILICONES
Schedule 10
Schedule 4
Appendix F, clause 4
SILODOSIN
Schedule 4
SILTUXIMAB
Schedule 4
SILVER
Schedule 2
SILVER NITRATE
cross reference: SILVER SALTS
Schedule 6
Appendix E, clause 3
SILVER OXIDE
Appendix B, clause 3
SILVER SULFADIAZINE
Schedule 4
SIMAZINE
Appendix B, clause 3
SIMEPREVIR
Schedule 4
SIMVASTATIN
Schedule 4
SINBIOALLETHRIN
Schedule 6
Schedule 5
SINGLE‑USE TUBES
Appendix A, clause 1
SIPONIMOD
Schedule 4
SIROLIMUS
Schedule 4
SISOMICIN
Schedule 4
SITAGLIPTIN
Schedule 4
SITAXENTAN
Schedule 4
Appendix D, clause 6
Appendix F, clause 4
Appendix L, clause 2
SLIMICIDES
Appendix A, clause 1
SODIUM ALUMINATE
Schedule 6
Appendix E, clause 3
Appendix F, clause 4
SODIUM BICARBONATE
Appendix B, clause 3
SODIUM BROMATE
Schedule 6
Appendix E, clause 3
SODIUM BROMIDE
Schedule 5
Schedule 4
SODIUM CELLULOSE PHOSPHATE
Schedule 4
SODIUM CHLORATE
Schedule 5
Appendix E, clause 3
Appendix F, clause 4
SODIUM CROMOGLYCATE
Schedule 4
Schedule 2
SODIUM DIACETATE
Schedule 5
Appendix E, clause 3
SODIUM DICHLOROISOCYANURATE
Appendix E, clause 3
SODIUM DODECYLBENZENE SULFONATE
Schedule 5
Appendix E, clause 3, Part
Appendix F, clause 4
SODIUM FLUORIDE
Appendix F, clause 4
SODIUM GLYCEROPHOSPHATE HYDRATE
Schedule 4
SODIUM HYDROGEN SULFATE
Schedule 5
Appendix E, clause 3
Appendix F, clause 4
SODIUM HYDROSULFITE
Schedule 5
Appendix F, clause 4
SODIUM HYDROXIDE
cross reference: LYE WATER
Schedule 10
Schedule 6
Schedule 5
Appendix E, clause 3
Appendix F, clause 4
SODIUM LAURETH‑6 CARBOXYLATE
Schedule 5
Appendix E, clause 3
Appendix F, clause 4
SODIUM METABISULPHITE
Schedule 5
Appendix E, clause 3
Appendix F, clause 4
SODIUM MORRHUATE
Schedule 4
SODIUM NITRITE
Schedule 7
Schedule 6
Schedule 5
Schedule 2
Appendix E, clause 3
Appendix F, clause 4
SODIUM NITROPRUSSIDE
Schedule 4
SODIUM OXYBATE
Schedule 8
Appendix D, clause 1
Appendix K, clause 1
SODIUM PERCARBONATE
Schedule 6
Schedule 5
Appendix E, clause 3
SODIUM PERSULFATE
Schedule 6
Appendix E, clause 3
Appendix F, clause 4
SODIUM PHENYLBUTYRATE
Schedule 4
SODIUM PHOSPHATE
Schedule 4
Schedule 3
SODIUM PICOSULFATE
Schedule 3
SODIUM POLYSTYRENE SULPHONATE
Schedule 5
Schedule 4
SODIUM PROPIONATE
Appendix B, clause 3
SODIUM SALICYLATE
Schedule 4
SODIUM STANNATE
Schedule 5,
Appendix E, clause 3
SODIUM SULFIDE
Schedule 6
Schedule 5
Appendix E, clause 3
Appendix F, clause 4
SODIUM TETRADECYLSULFATE
Schedule 4
SODIUM TRICHLOROACETATE
Appendix E, clause 3
SODIUM ZIRCONIUM CYCLOSILICATE.
Schedule 4
SODIUMHYDROSULFITE
Appendix E, clause 3
SOFOSBUVIR
Schedule 4
SOLASODINE
Schedule 4
SOLIFENACIN
Schedule 4
SOMAPACITAN
Schedule 4
SOMATOSTATIN
Schedule 4
SOMATOTROPIN EQUINE
Schedule 4
SOMATROPIN
cross reference: HUMAN GROWTH HORMONE
Schedule 4
Appendix D, clause 5
Appendix G, clause 1
SONIDEGIB
Schedule 4
SONTOQUINE
Schedule 4
SORAFENIB
Schedule 4
SOTALOL
Schedule 4
SOTORASIB
Schedule 4
SOTROVIMAB
Schedule 4
SPARFLOXACIN
Schedule 4
SPARTEINE
Schedule 4
SPECTINOMYCIN
Schedule 4
SPINETORAM
Schedule 5
SPINOSAD
Schedule 5
SPIRAMYCIN
Schedule 4
SPIRAPRIL
Schedule 4
SPIRONOLACTONE
Schedule 4
SPIROPIDION
Schedule 6
SPIROTETRAMAT
Schedule 6
SPIROXAMINE
Schedule 6
SQUILL
Schedule 2
STANOLONE
Schedule 4
Appendix D, clause 5 (Anabolic and/or androgenic steroidal agents)
STANOZOLOL
Schedule 4
Appendix D, clause 5 (Anabolic and/or androgenic steroidal agents)
STAR ANISE OIL
Schedule 5
STAVUDINE
Schedule 4
STENABOLIC (SR9009) and other synthetic REV‑ERB agonists
cross reference: SR9011, GSK2945, GSK0999, GSK5072, GSK2667
Schedule 4
Appendix D, clause 5
STENBOLONE
Schedule 4
Appendix D, clause 5 (Anabolic and/or androgenic steroidal agents)
STERIC ACID
Appendix B, clause 3
STEROID HORMONES
Schedule 4
STILBESTROL
cross reference: STILBOESTROL, DIETHYLSTILBESTROL
Schedule 4
STIRIPENTOL
Schedule 4
Appendix K, clause 1
STREPTODORNASE
Schedule 4
STREPTOKINASE
Schedule 4
STREPTOMYCES LYDICUS WYEC 108
Appendix B, clause 3
STREPTOMYCIN
Schedule 4
STRONTIUM RANELATE
Schedule 4
STROPHANTHINS
Schedule 4
STROPHANTHUS spp.
Schedule 4
Appendix G, clause 1
STRYCHNINE
cross reference: NUX VOMICA
Schedule 7
Schedule 4
Appendix E, clause 3
Appendix G, clause 1
Appendix J, clause 1
STRYCHNOS spp.
Schedule 4
STYRAMATE
Schedule 4
STYRENE
cross reference: DESIGNATED SOLVENT
Schedule 5
Appendix E, clause 3
Appendix F, clause 4
SUCCIMER
Schedule 4
SUCRALFATE
Appendix B, clause 3
SUCROFERRIC OXYHYDROXIDE
Schedule 4
SUFENTANIL
Schedule 8
SUGAMMADEX
Schedule 4
SULBACTAM
Schedule 4
SULCOFURON
Schedule 7
Schedule 6
Appendix E, clause 3
Appendix J, clause 1
SULCONAZOLE
Schedule 4
Schedule 2
SULESOMAB
Appendix B, clause 3
SULFACETAMIDE
Schedule 5
Schedule 4
Schedule 3
SULFADIAZINE
Schedule 5
Schedule 4
SULFADIMETHOXINE
Schedule 4
SULFADIMIDINE
Schedule 5
Schedule 4
SULFADOXINE
Schedule 4
SULFAFURAZOLE
Schedule 4
SULFAGUANIDINE
Schedule 4
SULFAMERAZINE
Schedule 5
Schedule 4
SULFAMETHIZOLE
Schedule 4
SULFAMETHOXAZOLE
Schedule 4
SULFAMETHOXYDIAZINE
Schedule 4
SULFAMETHOXYPYRIDAZINE
Schedule 4
SULFAMETROLE
Schedule 4
SULFAMIC ACID
Schedule 6
Schedule 5
Appendix E, clause 3
Appendix F, clause 4
SULFAMONOMETHOXINE
Schedule 4
SULFAMOXOLE
Schedule 4
SULFAPHENAZOLE
Schedule 4
SULFAPYRIDINE
Schedule 4
SULFAQUINOXALINE
Schedule 4
SULFASALAZINE
Schedule 4
SULFATHIAZOLE
Schedule 5
Schedule 4
SULFATROXAZOLE
Schedule 4
SULFENTRAZONE
Schedule 7
SULFINPYRAZONE
Schedule 4
SULFLURAMID
Schedule 6
SULFOMETURON‑METHYL
Schedule 5
SULFOMYXIN
Schedule 4
SULFONAMIDES
cross reference: SULFACETAMIDE, SULPHANILAMIDE
Schedule 4
SULFONMETHANE
cross reference: ALKYL SULFONALS, SULFONAL
Schedule 4
SULFOSULFURON
Appendix B, clause 3
SULFOTEP
Schedule 7
SULFOXAFLOR
Schedule 6
Schedule 5
SULFURIC ACID
Schedule 6
Appendix E, clause 3
Appendix F, clause 4
SULFURYL FLUORIDE
Schedule 6
SULINDAC
Schedule 4
SULPHATED POLYSACCHARIDES
Appendix B, clause 3
SULPROFOS
Schedule 6
SULTAMICILLIN
Schedule 4
SULTHIAME
Schedule 4
SUMATRIPTAN
Schedule 4
Schedule 3
Appendix H, clause 1
SUNIFIRAM
cross reference: RACETAMS
Schedule 4
SUNITINIB
Schedule 4
SUPROFEN
Schedule 4
SUTILAINS
Schedule 4
SUVOREXANT
Schedule 4
Appendix K, clause 1
SUXAMETHONIUM
Schedule 4
SUXETHONIUM
Schedule 4
SYMPHYTUM spp.
cross reference: COMFREY
Schedule 10
Schedule 5
Appendix F, clause 4
SYNTHETIC CANNABINOMIMETICS
Schedule 9
T
2,4,5‑T
Schedule 6
TACRINE
Schedule 4
TACROLIMUS
Schedule 4
TADALAFIL
Schedule 4
TAFAMIDIS
Schedule 4
TAFENOQUINE SUCCINATE
Schedule 4
TAFLUPROST
Schedule 4
TALAZOPARIB
Schedule 4
TALIGLUCERASE ALFA
Schedule 4
TALIMOGENE LAHERPAREPVEC
Schedule 4
TALLOW ALKYLAMINE ACETATES
Schedule 6
N‑TALLOW ALKYL‑1,3‑PROPANEDIAMINE DIACETATE
Schedule 6
TAMOXIFEN
Schedule 4
TAMSULOSIN
Schedule 4
TANACETUM VULGARE
cross reference: OIL OF TANSY, TANSY OIL
Schedule 4
TANNIC ACID
Appendix B, clause 3
TANNIC ACID/BENZYL ALCOHOL PRODUCT
Appendix B, clause 3
TAPENTADOL
Schedule 8
Appendix K, clause 1
TAR ACIDS
Schedule 6
TASONERMIN
Schedule 4
TAZAROTENE
Schedule 4
Appendix F, clause 4
TAZOBACTAM
Schedule 4
TB‑500
Schedule 4
Appendix D, clause 5
2,3,6‑TBA
Schedule 5
T‑CELL RECEPTOR ANTIBODY
Schedule 4
TCMTB
cross reference: 2‑[THIOCYANOMETHYLTHIO]BENZOTHIAZOLE
Schedule 6
TDE
cross reference: 1,1‑DICHLORO‑2,2‑BIS[4‑CHLOROPHENYL]ETHANE
Schedule 6
Schedule 5
TEBUCONAZOLE
cross reference: TERBUCONAZOLE
Schedule 5
TEBUFENOZIDE
Schedule 5
TEBUFENPYRAD
Schedule 6
TEBUTHIURON
Schedule 6
TEDUGLUTIDE
Schedule 4
TEFLUTHRIN
Schedule 7
Schedule 5
TEGAFUR
Schedule 4
TEGASEROD
Schedule 4
TEICOPLANIN
Schedule 4
TELAPREVIR
Schedule 4
TELBIVUDINE
Schedule 4
TELITHROMYCIN
Schedule 4
TELMISARTAN
Schedule 4
TELOTRISTAT ETHYL
Schedule 4
TEMAZEPAM
Schedule 4
Appendix D, clause 5 (Benzodiazepine derivatives)
Appendix K, clause 1
TEMEPHOS
Schedule 6
Schedule 5
TEMOZOLOMIDE
Schedule 4
TEMSIROLIMUS
Schedule 4
TENECTEPLASE
Schedule 4
TENIPOSIDE
Schedule 4
TENOCYCLIDINE
cross reference: TCP
Schedule 9
TENOFOVIR
Schedule 4
TENOXICAM
Schedule 4
TEPOTINIB
Schedule 4
TEPOXALIN
Schedule 4
TEPP
Schedule 8
TEPRALOXYDIM
Schedule 5
TERAZOSIN
Schedule 4
TERBACIL
Appendix B, clause 3,Part 3
TERBINAFINE
Schedule 4
Schedule 2
TERBUFOS
Schedule 7
TERBUTALINE
Schedule 4
Schedule 3
Appendix F, clause 4
TERBUTHYLAZINE
Schedule 6
TERBUTRYN
Schedule 5
TERFENADINE
Schedule 4
Appendix F, clause 4
TERIFLUNOMIDE
Schedule 4
Appendix F, clause 4
Appendix L, clause 2
TERIPARATIDE
Schedule 4
Appendix D, clause 1
TERLIPRESSIN
Schedule 4
TERMITE BARRIERS
Appendix A, clause 1
TERODILINE
Schedule 4
TEROPTERIN
Schedule 4
TERPENES, CHLORINATED
cross reference: CHLORINATED TERPENES
Schedule 6
Appendix E, clause 3
Appendix F, clause 4
TESTOLACTONE
Schedule 4
Appendix D, clause 5 (Anabolic and/or androgenic steroidal agents)
TESTOSTERONE
Schedule 6
Schedule 4
Appendix D, clause 5 (Anabolic and/or androgenic steroidal agents)
Appendix G, clause 1
TETANUS ANTITOXIN
Schedule 4
TETANUS TOXOID
cross reference: TRIPLE ANTIGEN VACCINE
Schedule 4
1,3,5,7‑TETRAAZATRICYLO[3.3.1.13,7] DECANE
cross reference: HEXAMINE, HEXAMETHYLENETETRAMINE, METHENAMINE
Schedule 5
TETRABENAZINE
Schedule 4
TETRACAINE
cross reference: AMETHOCAINE
Schedule 4
Schedule 2
TETRACHLOROETHANE
Schedule 7
Appendix E, clause 3
Appendix F, clause 4
Appendix J, clause 1
TETRACHLOROETHYLENE
cross reference: DESIGNATED SOLVENT
Schedule 6
Schedule 5
Schedule 2
Appendix E, clause 3
Appendix F, clause 4
TETRACHLORVINPHOS
Schedule 5
TETRACONAZOLE
Schedule 6
Schedule 5
TETRACOSACTIDE
Schedule 4
TETRACOSACTRIN
cross reference: TETRACOSACTIDE
TETRACYCLINE
Schedule 5
Schedule 4
TETRADIFON
Schedule 6
TETRAETHYLAMMONIUM
Schedule 4
TETRAHYDROCANNABINOLIC ACID
cross reference: NABIXIMOLS, TETRAHYDROCANNABINOLS, CANNABIS
TETRAHYDROCANNABINOLS
cross reference: CANNABIS, HEMP SEED OIL, NABIXIMOLS
Schedule 9
Schedule 8
Appendix D, clause 1
Appendix K, clause 1
TETRAHYDROCANNABIDIVAROL
cross reference: NABIXIMOLS, TETRAHYDROCANNABINOLS, CANNABIS
TETRAHYDROFURFURYL ALCOHOL
Schedule 6
TETRAHYDROZOLINE
cross reference: TETRYZOLINE
2,2',6,6'‑TETRAISOPROPYL‑DIPHENYL‑CARBODIIMIDE
cross reference: STABAXOL
Schedule 7
Schedule 6
Appendix J, clause 1
TETRAMETHRIN
Schedule 5
TETRAMISOLE
Schedule 6
TETRANILIPROLE
Schedule 5
TETROXOPRIM
Schedule 4
TETRYZOLINE
cross reference: TETRAHYDROZOLINE
Schedule 2
Appendix F, clause 4
TEZACAFTOR
Schedule 4
THALIDOMIDE
Schedule 4
Appendix D, clause 2
Appendix F, clause 4
Appendix L, clause 2
THALLIUM
cross reference: THALLIUM SULFATE
Schedule 7
Appendix J, clause 1
THAUMATIN
Appendix B, clause 3
THEBACON
Schedule 8
THEBAINE
Schedule 8
THENYLDIAMINE
Schedule 4
Appendix K, clause 1
THEOPHYLLINE
Schedule 4
Schedule 3
THEVETIA PERUVIANA
Schedule 4
THEVETIN
Schedule 4
THIABENDAZOLE
Schedule 5
Schedule 2
THIACETARSAMIDE
Schedule 4
THIACLOPRID
Schedule 6
THIAMBUTOSINE
Schedule 4
THIAMETHOXAM
Schedule 6
Schedule 5
THIAZAFLURON
Schedule 6
THIAZOPYR
Schedule 5
THIAZOSULFONE
Schedule 4
THIDIAZURON
Appendix B, clause 3
THIETHYLPERAZINE
Schedule 4
Appendix K, clause 1
THIFENSULFURON
Schedule 5
THIOACETAZONE
Schedule 4
THIOBENCARB
Schedule 5
THIOCARLIDE
Schedule 4
THIODICARB
Schedule 6
Schedule 5
THIOFANOX
Schedule 7
THIOFENTANYL
Schedule 9
THIOGUANINE
cross reference: TIOGUANINE
THIOMESTERONE
cross reference: TIOMESTERONE
Schedule 4
Appendix D, clause 5 (Anabolic and/or androgenic steroidal agents)
THIOMETON
Schedule 6
THIOPENTAL
Schedule 4
THIOPENTONE
cross reference: THIOPENTAL
THIOPHANATE‑METHYL
Schedule 6
Schedule 5
THIOPROPAZATE
Schedule 4
Appendix K, clause 1
THIOPROPERAZINE
Schedule 4
THIORIDAZINE
Schedule 4
Appendix K, clause 1
THIOSTREPTON
Schedule 4
THIOTEPA
cross reference: TRIETHYLENE THIOPHOSPHORAMIDE
Schedule 4
THIOTHIXENE
Schedule 4
Appendix K, clause 1
THIOURACIL
Schedule 4
THIOUREA
cross reference: ALKYL THIOUREAS
Schedule 6
Schedule 4
Appendix E, clause 3
Appendix F, clause 4
THIRAM
Schedule 6
THUJONE
Schedule 6
Appendix E, clause 3
THYME OIL
Schedule 5
Appendix E, clause 3
THYMOL
Schedule 6
THYMOSIN BETA 4 (THYMOSIN β4)
Schedule 4
Appendix D, clause 5
THYMOXAMINE
Schedule 4
THYROID
Schedule 4
THYROTROPHIN
cross reference: TSH
Schedule 4
THYROXINE
Schedule 4
Appendix G, clause 1
TIAFENACIL
Appendix B, clause 3
TIAGABINE
Schedule 4
TIAMULIN
Schedule 4
TIANEPTINE
Schedule 4
Appendix D, clause 5
TIAPROFENIC ACID
Schedule 4
TIARAMIDE
Schedule 4
TIBOLONE
Schedule 4
TICAGRELOR
Schedule 4
TICARCILLIN
Schedule 4
TICLOPIDINE
Schedule 4
TIEMONIUM
Schedule 4
TIENILIC ACID
Schedule 4
TIGECYCLINE
Schedule 4
TIGILANOL TIGLATE
Schedule 4
TIGLOIDINE
Schedule 4
TILDIPIROSIN
Schedule 4
TILETAMINE
Schedule 4
TILIDINE
Schedule 8
TILMANOCEPT
Schedule 4
TILMICOSIN
Schedule 4
TILUDRONIC ACID
cross reference: DISODIUM TILUDRONATE
Schedule 4
TIMBER
cross reference: WALLBOARD
Appendix A, clause 1
TIMOLOL
Schedule 4
TIMOTHY‑GRASS POLLEN EXTRACT
cross reference: PHLEUM PRATENSE POLLEN EXTRACT
Schedule 4
TIN ORGANIC COMPOUNDS
cross reference: DIALKYL TIN COMPOUNDS, DIBUTYL TIN COMPOUNDS, DIETHYL TIN COMPOUNDS, DIMETHYL TIN DICHLORIDE, DIMETHYL TIN COMPOUNDS, DIPROPYL TIN COMPOUNDS, FENBUTATIN OXIDE, ORGANO TIN‑COMPOUNDS, TBTO, TRIALKYL TIN COMPOUNDS, TRIBUTYL TIN COMPOUNDS, TRIETHYL TIN COMPOUNDS, TRIMETHYL TIN COMPOUNDS, TRIPHENYL TIN COMPOUNDS, TRIPROPYL TIN COMPOUNDS
Schedule 7
TINIDAZOLE
Schedule 4
TINZAPARIN
Schedule 4
TIOCARBAZIL
Schedule 5
TIOCONAZOLE
Schedule 4
Schedule 3
Schedule 2
Appendix H, clause 1
TIOGUANINE
cross reference: THIOGUANINE
Schedule 4
TIOTROPIUM
Schedule 4
TIPEPIDINE
Schedule 4
TIPIRACIL
Schedule 4
TIPRANAVIR
Schedule 4
TIRILAZAD
Schedule 4
TIROFIBAN
Schedule 4
TIXAGEVIMAB
Schedule 4
TOBRAMYCIN
Schedule 4
TOCAINIDE
Schedule 4
TOCERANIB
Schedule 4
TOCILIZUMAB
Schedule 4
TOFACITINIB
Schedule 4
TOLAZAMIDE
Schedule 4
TOLAZOLINE
Schedule 4
TOLBUTAMIDE
Schedule 4
TOLCAPONE
Schedule 4
TOLCLOFOS‑METHYL
Schedule 5
TOLFENAMIC ACID
Schedule 4
o‑TOLIDINE
Schedule 7
Appendix E, clause 3
Appendix J, clause 1
TOLMETIN
Schedule 4
TOLONIUM
Schedule 4
TOLPROPAMINE
Schedule 4
TOLRESTAT
Schedule 4
TOLTERODINE
Schedule 4
TOLTRAZURIL
Schedule 5
TOLUENE
cross reference: XYLENE
Schedule 6
Appendix E, clause 3
Appendix F, clause 4
2,4‑TOLUENEDIAMINE
Schedule 10
TOLUENEDIAMINES
Schedule 10
Schedule 6
Appendix E, clause 3
Appendix F, clause 4
o‑TOLUIDINE
Schedule 10
TOLVAPTAN
Schedule 4
TOLYLFLUANID
Schedule 6
TOPIRAMATE
Schedule 4
TOPOTECAN
Schedule 4
TOPRAMEZONE
Schedule 5
TORASEMIDE
Schedule 4
TOREMIFENE
Schedule 4
TOXOIDS
Schedule 4
TRABECTEDIN
Schedule 4
Appendix K, clause 1
TRALKOXYDIM
Schedule 5
TRAMADOL
Schedule 4
Appendix K, clause 1
TRAMAZOLINE
Schedule 2
Appendix F, clause 4
TRAMETINIB DIMETHYL SULFOXIDE
Schedule 4
TRANDOLAPRIL
Schedule 4
TRANEXAMIC ACID
cross reference: CETYL TRANEXAMATE
Schedule 4
TRANSFLUTHRIN
Schedule 6
TRANYLCYPROMINE
Schedule 4
Appendix K, clause 1
TRASTUZUMAB
Schedule 4
TRASTUZUMAB DERUXTECAN
Schedule 4
Appendix L, clause 2
TRASTUZUMAB EMTANSINE
Schedule 4
TRAVOPROST
Schedule 4
TRAZODONE
Schedule 4
TRENBOLONE
cross reference: TRIENBOLONE, TRIENOLONE
Schedule 5
Schedule 4
Appendix D, clause 5 (Anabolic and/or androgenic steroidal agents)
TREOSULPHAN
Schedule 4
TREPROSTINIL
Schedule 4
TRESTOLONE
Schedule 4
Appendix D, clause 5 (androgenic steroidal agents)
TRETAMINE
Schedule 4
TRETINOIN
Schedule 4
Appendix D, clause 4
Appendix F, clause 4
Appendix L, clause 2
TRIACETYLOLEANDOMYCIN
Schedule 4
TRIADIMEFON
Schedule 6
Schedule 5
TRIADIMENOL
Schedule 5
TRI‑ALLATE
Schedule 5
TRIAMCINOLONE
Schedule 4
Schedule 3
Schedule 2
Appendix F, clause 4, Part 2
Appendix H, clause 1
TRIAMIPHOS
Schedule 7
TRIAMTERENE
Schedule 4
TRIASULFURON
Appendix B, clause 3
TRIAZBUTIL
Schedule 7
TRIAZIQUONE
Schedule 4
TRIAZOLAM
Schedule 4
Appendix D, clause 5 (benzodiazepine derivatives)
TRIBENURON‑METHYL
Schedule 5
TRIBUFOS
cross reference: s,s,s‑TRIBUTYLPHOSPHOROTRITHIOATE
Schedule 7
TRICHLORFON
cross reference: METRIFONATE
Schedule 6
TRICHLORMETHIAZIDE
Schedule 4
TRICHLOROACETIC ACID
Schedule 6
Schedule 5
Schedule 4
Appendix E, clause 3
Appendix F, clause 4
TRICHLOROACETIC ACID ALKALI SALTS
Schedule 5
Appendix E, clause 3
1,1,1‑TRICHLOROETHANE
cross reference: DESIGNATED SOLVENT
Schedule 10
Schedule 5
Appendix E, clause 3
Appendix F, clause 4
TRICHLOROETHYLENE
cross reference: TRICHLOROETHENE
Schedule 6
Schedule 4
Appendix E, clause 3
Appendix F, clause 4
TRICHLOROISOCYANURIC ACID
cross reference: CHLORINATING COMPOUNDS
Appendix E, clause 3
TRICHLOROPHENOL
Schedule 6
Appendix F, clause 4
TRICHODERMA HARZIANUM
Appendix B, clause 3
TRICHODESMA AFRICANA
Schedule 10
TRICLABENDAZOLE
Schedule 6
TRICLOFOS
Schedule 4
TRICLOPYR
Schedule 6
TRICLOSAN
Schedule 6
TRICYCLAMOL
Schedule 4
TRIDEMORPH
Schedule 6
TRIDIHEXETHYL
Schedule 4
TRIDIPHANE
Schedule 5
TRIENTINE
Schedule 4
TRIETAZINE
Schedule 5
TRIETHANOLAMINE
cross reference: TROLAMINE
TRIETHYL PHOSPHATE
Schedule 6
Appendix E, clause 3
TRIETHYLENE GLYCOL
Appendix B, clause 3
TRIFAROTENE
Schedule 4
TRIFLOXYSTROBIN
Schedule 5
TRIFLOXYSULFURON
Appendix B, clause 3
TRIFLUDIMOXAZIN
Schedule 5
TRIFLUMIZOLE
Schedule 5
TRIFLUMURON
Schedule 5
TRIFLUOPERAZINE
Schedule 4
Appendix K, clause 1
TRIFLUOROMETHANESULFONIC ACID
Schedule 6
Appendix E, clause 3
Appendix F, clause 4
1‑(3‑TRIFLUOROMETHYLPHENYL)PIPERAZINE
cross reference: TFMPP
Schedule 9
TRIFLUPERIDOL
Schedule 4
TRIFLUPROMAZINE
Schedule 4
TRIFLURALIN
Appendix B, clause 3
TRIFLURIDINE
Schedule 4
TRIFORINE
Appendix B, clause 3
TRIHEXYPHENIDYL
cross reference: BENZHEXOL
Schedule 4
TRIISOPROPANOLAMINE LAURYL ETHER SULFATE
Schedule 5
Appendix E, clause 3
Appendix F, clause 4
TRILOSTANE
Schedule 4
TRIMEPERIDINE
Schedule 9
TRIMEPRAZINE
cross reference: ALIMEMAZINE
TRIMETAPHAN
Schedule 4
TRIMETHOPRIM
Schedule 4
3,4,5‑TRIMETHOXY‑ α –METHYLPHENYLETHYLAMINE
cross reference: TMA
Schedule 9
3,4,5‑TRIMETHOXYPHENETHYLAMINE
cross reference: MESCALINE, METHOXYPHENAMINE, METHOXY‑PHENYLETHYLAMINE
Schedule 9
1‑(3,4,5‑TRIMETHOXYPHENYL)‑2‑AMINOBUTANE
Schedule 9
TRIMIPRAMINE
Schedule 4
Appendix K, clause 1
TRIMUSTINE
Schedule 4
TRINEXAPAC‑ETHYL
Schedule 5
TRINITROPHENOL
Schedule 6
Schedule 4
3,6,9‑TRIOXAUNDECANEDIOIC ACID
Schedule 5
Appendix F, clause 4
TRIOXYSALEN
Schedule 4
TRIPARANOL
Schedule 10
TRIPELENNAMINE
Schedule 4
TRIPLE ANTIGEN VACCINE
cross reference: DIPHTHERIA TOXOID, PERTUSSIS ANTIGEN, TETANUS TOXOID
TRIPROLIDINE
Schedule 4
Schedule 3
Schedule 2
Appendix K, clause 1
TRIPTORELIN
Schedule 4
TRISODIUM NITRILOTRIACETATE
Schedule 6
TRITICONAZOLE
Schedule 5
TROGLITAZONE
Schedule 4
TROLAMINE
Schedule 5
Schedule 4
Appendix E, clause 3
Appendix F, clause 4
TROMETAMOL
Schedule 4
TROPICAMIDE
Schedule 4
TROPISETRON
Schedule 4
TROVAFLOXACIN
Schedule 4
TROXIDONE
Schedule 4
TRYPTOPHAN
Schedule 4
TUAMINOHEPTANE
Schedule 2
TUCATINIB
Schedule 4
TUBERCULIN
Schedule 4
TUBOCURARINE
Schedule 4
TULATHROMYCIN
Schedule 4
TULOBUTEROL
Schedule 4
TURPENTINE OIL
cross reference: OIL OF TURPENTINE
Schedule 5
Appendix E, clause 3
TUSSILAGO FARFARA
cross reference: COLTSFOOT
Schedule 10
TYLOSIN
Schedule 4
TYMAZOLINE
Schedule 4
Appendix F, clause 4
TYPHOID VACCINE
Schedule 4
U
ULIPRISTAL
Schedule 4
Schedule 3
Appendix H, clause 1
ULOCLADIUM OUDEMANSII
Appendix B, clause 3
UMECLIDINIUM
Schedule 4
UNIFIRAM
cross reference: RACETAMS
Schedule 4
UNOPROSTONE
Schedule 4
UPADACITINIB
Schedule 4
URACIL
Schedule 4
URAPIDIL
Schedule 4
UREA
Appendix B, clause 3
URETHANE
Schedule 4
UROFOLLITROPIN
cross reference: FOLLICLE‑STIMULATING HORMONE, HUMAN
Schedule 4
Appendix D, clause 1
UROKINASE
Schedule 4
URSODEOXYCHOLIC ACID
Schedule 4
USTEKINUMAB
Schedule 4
V
VACCINES
Schedule 4
VACCINES – PLASMID DNA
cross reference: PLASMID DNA (rE. coli DH5α pINGhT)
Schedule 4
VACCINIA VIRUS VACCINE
Schedule 4
VALACICLOVIR
Schedule 4
VALDECOXIB
Schedule 4
VALGANCICLOVIR
Schedule 4
VALNOCTAMIDE
Schedule 4
VALPROIC ACID
Schedule 4
VALSARTAN
Schedule 4
VAMIDOTHION
Schedule 6
VANCOMYCIN
Schedule 4
VANDETANIB
Schedule 4
VARDENAFIL
Schedule 4
VARENICLINE
Schedule 4
VARICELLA VACCINE
Schedule 4
VARICELLA ZOSTER VIRUS GLYCOPROTEIN E ANTIGEN (RECOMBINANT)
cross reference: RECOMBINANT VARICELLA ZOSTER VIRUS GLYCOPROTEIN E ANTIGEN
VASOPRESSIN
Schedule 4
VECURONIUM
Schedule 4
VEDAPROFEN
Schedule 4
VEDOLIZUMAB
Schedule 4
VELAGLUCERASE ALFA
Schedule 4
VELPATASVIR
Schedule 4
VEMURAFENIB
Schedule 4
VENETOCLAX
Schedule 4
VENLAFAXINE
Schedule 4
VERAPAMIL
Schedule 4
VERATRUM
Schedule 4
VERICIGUAT
Schedule 4
VERNAKALANT
Schedule 4
VERNOLATE
Schedule 5
VERTEPORFIN
Schedule 4
VETIVER OIL
Appendix B, clause 3
VIDARABINE
Schedule 4
VIGABATRIN
Schedule 4
VILANTEROL
Schedule 4
VILDAGLIPTIN
Schedule 4
VILOXAZINE
Schedule 4
VINBLASTINE
Schedule 4
VINCAMINE
Schedule 4
VINCLOZOLIN
Schedule 6
Appendix F, clause 4
VINCRISTINE
Schedule 4
VINDESINE
Schedule 4
VINFLUNINE
Schedule 4
VINORELBINE
Schedule 4
VINYL ACETATE MONOMER
Schedule 6
Appendix E, clause 3
Appendix F, clause 4
VINYL CHLORIDE
Schedule 7
Appendix J, clause 1
VINYL ETHER
Schedule 4
VIRGINIAMYCIN
Schedule 5
Schedule 4
VISMODEGIB
Schedule 4
VISNADINE
Schedule 4
VITAMIN A
Schedule 4
VITAMIN D
cross reference: COLECALCIFEROL, ERGOCALCIFEROL
Schedule 4
Schedule 3
Appendix H, clause 1
VITAMIN K
cross reference: PHYTOMENADIONE
Appendix B, clause 3
VITREOUS ENAMELS
Appendix A, clause 1
VORAPAXAR
Schedule 4
VORETIGENE NEPARVOVEC
Schedule 4
VORICONAZOLE
Schedule 4
VORINOSTAT
Schedule 4
VORTIOXETINE
Schedule 4
VOSORITIDE
Schedule 4
VOXILAPREVIR
Schedule 4
W
WALLBOARD
cross reference: TIMBER
Appendix A, clause 1
WARFARIN
Schedule 6
Schedule 5
Schedule 4
WRITING CORRECTION PENS
Appendix A, clause 1
X
XAMOTEROL
Schedule 4
XANTHINOL NICOTINATE
Schedule 4
XANTHOPHYLL
cross reference: LUTEIN
Appendix B, clause 3
XIMELAGATRAN
Schedule 4
XIPAMIDE
Schedule 4
XYLANASE derived from Aspergillus niger
Appendix B, clause 3
XYLAZINE
Schedule 4
XYLENE
cross reference: TOLUENE
Schedule 6
Appendix E, clause 3
Appendix F, clause 4
XYLOMETAZOLINE
Schedule 2
Appendix F, clause 4
Y
YLANG YLANG OIL
Appendix B, clause 3
YOHIMBINE
cross reference: ASPIDOSPERMA QUEBRACHO
Schedule 4
Z
(Z)‑9‑TRICOSENE
cross reference: TRICOSENE
Appendix B, clause 3
ZAFIRLUKAST
Schedule 4
ZALCITABINE
Schedule 4
ZALEPLON
Schedule 4
ZANAMIVIR
Schedule 4
ZANUBRUTINIB
Schedule 4
ZERANOL
Schedule 6
Schedule 4
ZETA‑CYPERMETHRIN
Schedule 7
Schedule 6
ZIDOVUDINE
Schedule 4
ZILPATEROL
Schedule 4
ZIMELDINE
Schedule 4
ZINC BORATE
Schedule 6
ZINC CHLORIDE
Schedule 4
Schedule 2
Appendix E, clause 3
ZINC COMPOUNDS
Schedule 4
ZINC LACTATE
Schedule 6
Appendix F, clause 4
ZINC NAPHTHENATE
Appendix B, clause 3
ZINC para‑PHENOLSULFONATE
Schedule 6
ZINC SULFATE
Schedule 6
Appendix E, clause 3
Appendix F, clause 4
ZINEB
cross reference: DITHIOCARBAMATES, MANCOZEB, PROPINEB, THIRAM
Schedule 5
ZIPRASIDONE
Schedule 4
Appendix K, clause 1
ZIRAM
Schedule 7
Schedule 6
ZOLAZEPAM
Schedule 4
ZOLEDRONIC ACID
Schedule 4
ZOLMITRIPTAN
Schedule 4
Schedule 3
Appendix H, clause 1
ZOLPIDEM
Schedule 4
Appendix K, clause 1
ZONISAMIDE
Schedule 4
Appendix K, clause 1
ZOPICLONE
Schedule 4
Appendix K, clause 1
ZOXAZOLAMINE
Schedule 4
ZUCLOPENTHIXOL
Schedule 4
0
0
0